{
  "version": "0.19.0",
  "last_updated": "2025-08-22",
  "diagnoses": [
    {
      "id": "aaa",
      "name": "Abdominal Aortic Aneurysm (AAA)",
      "description": "A dilation of the abdominal aorta (>1.5 times normal size), usually located below the renal arteries.",
      "features": [
        "Majority are asymptomatic",
        "Abdominal or back pain when symptomatic",
        "Pulsatile abdominal mass on exam",
        "Abdominal bruit",
        "Syncope may indicate rupture",
        "Risk factors: smoking, atherosclerosis, hypertension, male gender, age >50, family history"
      ],
      "workup": [
        "Abdominal ultrasound (screening and surveillance)",
        "CT angiogram (definitive diagnosis, especially for symptomatic disease)",
        "Chest X-ray if dissection suspected",
        "Blood pressure measurement in both arms",
        "ECG to exclude cardiac causes"
      ],
      "management": [
        "One-time ultrasound screening for men >65 with smoking history or family history",
        "AAA <3cm: No further workup",
        "AAA 3-3.9cm: Repeat ultrasound every 1-3 years",
        "AAA 4-5.4cm: Repeat ultrasound every 6 months",
        "AAA ≥5.5cm: Surgical repair (sometimes 5.0cm if Marfan's or small person)",
        "All symptomatic AAA: Urgent surgical intervention regardless of size",
        "Smoking cessation",
        "Blood pressure control",
        "Statin therapy",
        "Antiplatelet therapy"
      ],
      "pearls": [
        "Screening recommended for men 65-75 with smoking history",
        "Consider screening in women >65 with risk factors",
        "Regular surveillance imaging critical for size monitoring",
        "Rapid growth (>0.5cm/year) or symptoms warrant intervention",
        "Open surgical repair vs endovascular repair based on anatomy",
        "Post-operative surveillance for endoleaks and complications",
        "Family screening for first-degree relatives",
        "Multidisciplinary approach with vascular surgery"
      ]
    },
    {
      "id": "acs",
      "name": "Acute Coronary Syndrome (UA/NSTEMI/STEMI)",
      "description": "Spectrum of conditions from unstable angina to myocardial infarction resulting from coronary artery ischemia.",
      "features": [
        "Chest pain (squeezing, pressure, substernal) - new, worsening, or at rest",
        "Shortness of breath",
        "Nausea/vomiting",
        "Diaphoresis (very specific for ACS)",
        "Women, elderly, diabetics may present atypically without chest pain",
        "Unstable angina: New/worsening chest pain or pain at rest without enzyme elevation",
        "NSTEMI: Ischemia with cardiac enzyme elevation",
        "STEMI: ST elevation with cardiac enzyme elevation",
        "Coronary artery disease risk factors: HTN (most common), smoking, hyperlipidemia, DM, obesity, age (>45M/>55F), family history"
      ],
      "workup": [
        "ECG within 10 minutes - repeat every 10 minutes if ACS suspected [WHY: Identifies STEMI requiring immediate PCI, localizes infarct territory, detects arrhythmias]",
        "STEMI: ST elevation ≥1mm in ≥2 contiguous leads (II,III,aVF=inferior; V1-V4=anterior; I,aVL,V5-V6=lateral)",
        "NSTEMI/Unstable angina: ST depression, T-wave inversion, or normal ECG",
        "New LBBB = STEMI equivalent",
        "Hyperacute T-waves = earliest sign of infarction",
        "Cardiac biomarkers: Serial troponin measurements [WHY: Confirms myocardial necrosis, differentiates UA from NSTEMI, guides treatment intensity]",
        "Troponin I (preferred) - rises 1-3h, peaks 24h, elevated up to 2 weeks",
        "CK-MB for reinfarction (rises 4h, peaks 24h, returns to baseline 36-48h)",
        "Serial troponins: Negative enzymes exclude MI by 8h (12-24h for high-risk)",
        "Reinfarction: Troponin increase >20% or new rise",
        "NOTE: Renal failure can falsely elevate troponin",
        "Chest X-ray if alternative diagnosis suspected [WHY: Rules out aortic dissection, pneumothorax, pneumonia as chest pain causes]",
        "Coronary anatomy: LAD (anterior LV), LCx (lateral LV, SA/AV node), RCA (inferior LV, RV, SA/AV node)"
      ],
      "management": [
        "Immediate aspirin 325mg chewed + P2Y12 inhibitor (clopidogrel 600mg/ticagrelor 180mg/prasugrel 60mg)",
        "Oxygen only if hypoxic (SpO2 <94%)",
        "Nitroglycerin SL 0.4mg q5min x3 PRN chest pain (contraindicated in RV MI, PDE-5 inhibitor use)",
        "Morphine for refractory pain",
        "Anticoagulation: Heparin bolus + infusion per protocol",
        "Beta-blocker (metoprolol/atenolol) unless contraindicated",
        "High-intensity statin (atorvastatin 40-80mg/rosuvastatin 20-40mg)",
        "STEMI: PCI preferred (<90 min door-to-balloon) or thrombolysis if PCI unavailable",
        "UA/NSTEMI: TIMI risk stratification - early invasive (≤24-48h) for score 3-7",
        "TIMI 0-2: Medical therapy + stress testing if asymptomatic",
        "Right-sided MI (40% of inferior MI): Avoid nitrates, consider fluid resuscitation",
        "Bradycardia/AV block in inferior MI: Atropine/transcutaneous pacing",
        "Cocaine-associated MI: Avoid beta-blockers, use benzodiazepines",
        "Continuous telemetry monitoring for VT/VF (most common early death cause)",
        "Pericarditis post-MI: Aspirin (avoid steroids for Dressler syndrome)"
      ],
      "pearls": [
        "TIMI Risk Score (1 point each): Age≥65, ≥3 CAD RF, known CAD, ASA in 7d, ≥2 angina episodes in 24h, ST changes ≥0.5mm, positive enzymes",
        "TIMI 3-7: Angiography within 24-48h; TIMI 0-2: Medical therapy + stress testing",
        "Right-sided MI: Preload dependent - avoid nitrates, consider fluids for hypotension",
        "Post-MI medications: ASA 81mg, P2Y12 inhibitor, beta-blocker, ACEI, high-intensity statin",
        "EF <40%: Initiate GDMT for HFrEF (ACEI/ARB/ARNI, beta-blocker, MRA, SGLT2i)",
        "Cardiac rehabilitation mandatory",
        "Follow-up: CIS within 1-2 weeks, labs (CBC, CMP, Mg) prior to visit",
        "Discharge documentation: History of GIB or No History of GIB",
        "Nutrition consult for PCM evaluation",
        "Protonix 40mg daily with DAPT for gastric protection",
        "SL nitroglycerin 0.4mg q5min x3 PRN chest pain",
        "Ambulate when chest pain-free",
        "Remove transdermal nitro ASAP to assess for CP recurrence",
        "Trend cardiac biomarkers q6h x3 sets",
        "Keep NPO for LHC except medications",
        "Complete angiogram checklist prior to cath",
        "Engage physician early for high-risk patients"
      ]
    },
    {
      "id": "acute_limb_ischemia",
      "name": "Acute Limb Ischemia (ALI)",
      "description": "Sudden decrease in limb perfusion requiring urgent intervention.",
      "features": ["Sudden limb pain", "Paresthesia", "Paralysis (late)"],
      "workup": [
        "Bedside vascular exam (Doppler)",
        "CTA runoff (definitive imaging if stable)",
        "Immediate vascular surgery consult"
      ],
      "management": [
        "IV heparin anticoagulation",
        "Analgesia, limb positioning (dependent)",
        "Urgent revascularization (surgical embolectomy, bypass, thrombolysis)"
      ],
      "pearls": [
        "Do not delay revascularization for imaging if limb immediately threatened",
        "Report recurrent limb pain, numbness, weakness",
        "Adherence to anticoagulation/antiplatelet therapy",
        "Vascular surgery follow-up"
      ]
    },
    {
      "id": "acute_mesenteric_ischemia",
      "name": "Acute Mesenteric Ischemia (AMI)",
      "description": "Insufficient blood supply to the intestines, often due to embolism or thrombosis.",
      "features": [
        "Severe abdominal pain out of proportion to exam",
        "Nausea/vomiting",
        "Diarrhea or occult GI bleeding"
      ],
      "workup": [
        "CTA abdomen (diagnostic)",
        "Lactate, metabolic acidosis labs",
        "Angiography (diagnosis + therapy in some cases)"
      ],
      "management": [
        "Aggressive resuscitation (IV fluids, broad-spectrum antibiotics)",
        "Systemic anticoagulation (heparin)",
        "Urgent revascularization (embolectomy, stent, bypass)",
        "Surgery for peritonitis/necrosis"
      ],
      "pearls": [
        "Do not delay operative intervention if peritonitis or shock",
        "Adherence to anticoagulation if indicated",
        "Report recurrent abdominal pain immediately",
        "Vascular surgery and gastroenterology follow-up"
      ]
    },
    {
      "id": "pericarditis",
      "name": "Acute Pericarditis",
      "description": "Inflammation of the pericardium, often presenting with chest pain.",
      "features": [
        "Pleuritic chest pain (worse with inspiration, relieved by sitting up/leaning forward)",
        "Pericardial friction rub (pathognomonic)",
        "EKG: diffuse ST elevations and PR depressions",
        "Fever",
        "Dyspnea"
      ],
      "workup": [
        "EKG: diffuse ST elevation and PR depression",
        "Troponins may be mildly elevated",
        "Echocardiogram useful for pericardial effusion",
        "CXR may show cardiomegaly if large effusion present",
        "ESR/CRP elevated",
        "Blood cultures if febrile; consider viral studies, autoimmune workup"
      ],
      "management": [
        "NSAIDs and colchicine are first-line",
        "Steroids if refractory",
        "Hospitalize if patient has high-risk features (e.g., pericardial effusion, tamponade physiology, immunocompromised, post-MI, trauma)"
      ],
      "pearls": [
        "Avoid anticoagulation in large effusion (tamponade risk)",
        "Repeat echo if effusion suspected or symptoms persist",
        "Monitor CRP for response",
        "Cardiology follow-up in 1–2 weeks",
        "Recurrence common - colchicine reduces recurrence rate",
        "Differentiate from myocardial infarction (troponins, ECG pattern)"
      ]
    },
    {
      "id": "angina",
      "name": "Angina",
      "description": "Chest pain or discomfort caused by reduced blood flow to the heart muscle. Includes stable angina, variant (Prinzmetal) angina, and microvascular angina.",
      "features": [
        "Chest discomfort (pressure, squeezing, heaviness, tightness)",
        "May radiate to jaw, neck, shoulders, arms, or back",
        "May be accompanied by dyspnea, nausea, diaphoresis",
        "Pattern varies by angina type (exertional vs rest vs microvascular)"
      ],
      "workup": [
        "12-lead ECG (may be normal at rest)",
        "Cardiac biomarkers (troponin) to rule out MI",
        "Stress testing (exercise or pharmacologic)",
        "Coronary angiography for high-risk features",
        "Advanced imaging (echo, nuclear, CT coronary angiography)"
      ],
      "management": [
        "Risk factor modification (smoking cessation, BP control, lipid management, diabetes control)",
        "Antiplatelet therapy (aspirin)",
        "Statin therapy",
        "Antianginal medications (beta-blockers, CCBs, nitrates)",
        "Sublingual nitroglycerin for acute episodes",
        "Revascularization (PCI or CABG) for appropriate candidates"
      ],
      "pearls": [
        "Three main types: stable (exertional), variant (vasospastic), and microvascular",
        "Always rule out acute coronary syndrome in new or worsening angina",
        "Patients should carry sublingual nitroglycerin",
        "Education: call EMS if chest pain persists >5 minutes or doesn't respond to nitroglycerin",
        "Regular cardiology follow-up for optimization of medical therapy"
      ],
      "subtypes": [
        {
          "id": "stable_angina",
          "name": "Stable (Chronic) Angina Pectoris",
          "description": "Myocardial ischemia secondary to exertion (increased oxygen demand).",
          "features": [
            "Chest discomfort (squeezing/pressure/substernal) with exertion",
            "Relieved by rest and/or nitroglycerin",
            "Never occurs at rest",
            "Predictable pattern",
            "May radiate to jaw, neck, left arm",
            "Usually asymptomatic at rest"
          ],
          "workup": [
            "ECG usually normal at rest",
            "Stress testing: exercise or pharmacologic (dobutamine/adenosine)",
            "Nuclear scans show decreased thallium uptake",
            "Echocardiogram with dobutamine shows wall motion abnormalities",
            "Coronary angiography if positive stress test + high-risk patient",
            "PET if equivocal stress test + atypical symptoms"
          ],
          "management": [
            "Lifestyle modifications (DASH diet, smoking cessation, weight loss, exercise)",
            "Control hypertension, diabetes, hyperlipidemia",
            "Medications: aspirin, statin, beta blocker",
            "Nitroglycerin as needed (decreases preload, relieves chest pain)",
            "CCB if beta blockers contraindicated",
            "Revascularization (PCI or CABG) if symptoms persist or anatomy is high risk"
          ],
          "pearls": [
            "Coronary Artery Disease Risk Factors: HTN (most common), smoking, hyperlipidemia, diabetes, obesity, age, family history",
            "Stress testing increases oxygen demand → ischemic changes (ST depression)",
            "Neither stable nor Prinzmetal angina elevates cardiac enzymes",
            "Indications for angiography: positive stress test + high-risk patient or equivocal stress test + atypical symptoms",
            "Monitor symptom frequency, tolerance to meds",
            "Regular risk factor modification follow-up",
            "Carry nitroglycerin at all times, use for chest pain episodes",
            "Call EMS if pain >5 minutes or not relieved by nitroglycerin",
            "Cardiology follow-up; repeat stress testing if symptoms worsen"
          ]
        },
        {
          "id": "variant_angina",
          "name": "Variant (Prinzmetal) Angina",
          "description": "Ischemia secondary to coronary artery spasm.",
          "features": [
            "Occurs at rest",
            "Often early morning hours",
            "Caused by coronary vasospasm",
            "Chest pain similar to stable angina but at rest",
            "May be associated with arrhythmias during episodes"
          ],
          "workup": [
            "ECG shows transient ST elevation that resolves after the episode (usually within 5–15 min)",
            "Coronary angiography (often normal or mild CAD, may show spasm with provocation)",
            "Ergonovine or acetylcholine provocation testing (specialized centers)",
            "Holter monitoring to capture episodes"
          ],
          "management": [
            "Calcium channel blockers and nitrates (relieve vasospasm)",
            "Avoid beta blockers, as they may worsen symptoms",
            "Smoking cessation (major trigger)",
            "Treat underlying coronary artery disease if present",
            "Long-acting nitrates for prevention"
          ],
          "pearls": [
            "Monitor angina episodes, adjust CCB/nitrate therapy",
            "Avoid precipitants (cocaine, smoking, cold exposure)",
            "Adherence to CCB/nitrate therapy",
            "Cardiology follow-up",
            "May require implantable loop recorder if episodes infrequent",
            "Consider autonomic dysfunction in some cases"
          ]
        },
        {
          "id": "microvascular_angina",
          "name": "Microvascular Angina (Cardiac Syndrome X)",
          "description": "Chest pain or discomfort due to coronary microvascular dysfunction.",
          "features": [
            "Angina-like chest pain, often prolonged and not always exertional",
            "Frequently in women"
          ],
          "workup": [
            "Stress testing (may be positive for ischemia)",
            "Coronary angiography (normal/mild disease)",
            "Coronary flow reserve testing (abnormal in microvascular angina)"
          ],
          "management": [
            "Antianginal therapy: β-blockers, CCBs, nitrates (variable efficacy)",
            "Risk factor modification (HTN, DM, lipids, obesity)",
            "ACEi/ARB and statins may improve endothelial function"
          ],
          "pearls": [
            "Symptom monitoring, risk factor management",
            "Adherence to medications for angina and risk factor control",
            "Seek urgent care for worsening or new typical angina symptoms",
            "Cardiology follow-up"
          ]
        }
      ]
    },
    {
      "id": "aortic_dissection",
      "name": "Aortic Dissection",
      "description": "Tearing of the tunica intima allowing blood to leak into the tunica media, creating a false lumen.",
      "features": [
        "Sudden severe tearing chest pain or interscapular back pain",
        "Older male patient typical presentation",
        "Hypertension common risk factor",
        "May present with syncope",
        "Blood pressure differential between arms",
        "Pulse deficits possible",
        "Neurological symptoms if carotid involvement",
        "Risk factors: hypertension, Marfan syndrome, Ehlers-Danlos, males >40"
      ],
      "workup": [
        "CT angiogram (CTA) - test of choice [WHY: Rapidly identifies dissection location, extent, and complications - critical for surgical planning in emergency setting]",
        "Magnetic resonance angiogram (MRA) - equal efficacy to CTA [WHY: Alternative when contrast contraindicated, excellent detail but takes longer - not ideal if unstable]",
        "Transesophageal echocardiogram (TEE) - equal efficacy [WHY: Bedside test, identifies pericardial effusion/tamponade, aortic regurgitation - useful in unstable patients]",
        "Chest X-ray: widened mediastinum (>8cm) [WHY: Quick screening test but only 60% sensitive - normal CXR doesn't rule out dissection]",
        "ECG to exclude myocardial infarction [WHY: Dissection can involve coronary ostia causing MI, changes treatment approach - thrombolytics contraindicated]",
        "Blood pressure measurement in both arms [WHY: >20 mmHg difference suggests subclavian involvement, indicates extent of dissection]",
        "Neurological examination [WHY: Carotid involvement causes stroke, affects surgical approach and prognosis]"
      ],
      "management": [
        "Surgical emergency - all unstable patients require intubation",
        "Blood pressure control: beta-blockers first (SBP <100, HR <60)",
        "Add nitroprusside if beta-blockers insufficient",
        "Never start with nitroprusside alone (causes reflex tachycardia)",
        "Type A (ascending aorta): Emergency surgical repair",
        "Type B (descending aorta): Medical management unless rupture, end-organ ischemia, or refractory hypertension",
        "Pain management with opioids",
        "Serial imaging at 3, 6, and 12 months"
      ],
      "pearls": [
        "Type A = proximal to left subclavian artery → surgery",
        "Type B = distal to left subclavian artery → medical management",
        "Beta-blockers are first-line for blood pressure control",
        "Avoid vasodilators without beta-blocker coverage",
        "Serial imaging to monitor for progression, redissections, new aneurysms",
        "Genetic testing for connective tissue disorders",
        "Family screening for hereditary conditions",
        "Long-term beta-blocker and blood pressure management",
        "Regular follow-up with cardiothoracic/vascular surgery"
      ],
      "clinical_triggers": {
        "symptoms_any": [
          "Sudden severe chest/back pain, tearing/ripping",
          "Syncope",
          "Stroke symptoms",
          "Malperfusion (limb/visceral ischemia)"
        ],
        "signs_any": [
          "BP differential between arms",
          "Pulse deficit",
          "New diastolic murmur (AR)",
          "Shock/tamponade signs if rupture"
        ]
      },
      "contraindications": {
        "beta_blocker_monotherapy": [
          "Avoid vasodilator without β-blocker (reflex tachycardia worsens dissection)"
        ]
      },
      "discharge": {
        "instructions": [
          "Adherence to lifelong BP control",
          "Immediate ED evaluation for recurrent chest/back pain or neuro deficits"
        ],
        "follow_up": ["Vascular/cardiothoracic follow-up"]
      }
    },
    {
      "id": "ar",
      "name": "Aortic Regurgitation",
      "description": "Backflow of blood from the aorta into the left ventricle due to aortic valve insufficiency.",
      "features": [
        "Etiology: Aortic root dilation, congenital bicuspid valve, rheumatic disease (most common outside US)",
        "Symptoms: Asymptomatic early; wide pulse pressure, 'water hammer' pulses",
        "Murmur: Decrescendo diastolic murmur, blowing quality, best at left sternal border",
        "Exertional dyspnea",
        "Fatigue",
        "Palpitations",
        "Angina"
      ],
      "workup": [
        "Transthoracic echo (severity, LV size/function, root/ascending aorta)",
        "ECG (LVH, nonspecific changes)",
        "CXR (cardiomegaly, aortic root dilation)",
        "BNP for prognostic info in chronic AR"
      ],
      "management": [
        "Treatment: Surgical correction",
        "Afterload reduction (ACEi/ARB, nifedipine) may improve symptoms in severe AR if not surgical candidate",
        "Treat underlying causes (syphilis, endocarditis, aortic root disease, etc.)",
        "Symptomatic severe AR or LV systolic dysfunction (LVEF ≤50%): AVR (surgical preferred)",
        "Asymptomatic severe AR with progressive LV dilation: AVR"
      ],
      "pearls": [
        "Avoid in isolated severe AR — prolongs diastole and worsens regurgitant volume",
        "Echo surveillance: mild q3–5y, moderate q1–2y, severe q6–12mo",
        "Monitor for new dyspnea, chest pain, palpitations",
        "Maintain good dental hygiene (endocarditis risk)",
        "Wide pulse pressure and bounding pulses are characteristic",
        "Diastolic murmur best heard at left sternal border with patient leaning forward"
      ]
    },
    {
      "id": "as",
      "name": "Aortic Stenosis",
      "description": "Narrowing of the aortic valve opening, restricting blood flow from the heart.",
      "features": [
        "Common in elderly (calcification), congenital bicuspid valve, rheumatic disease",
        "Symptoms: dyspnea, angina, dizziness, syncope",
        "Murmur: systolic crescendo-decrescendo, best at 2nd right intercostal space, radiates to neck",
        "Patients symptomatic with severe AS are at high risk of sudden death",
        "Exertional dyspnea",
        "Angina",
        "Syncope/presyncope",
        "Fatigue"
      ],
      "workup": [
        "Transthoracic echo (valve area, mean gradient, jet velocity, LV function)",
        "ECG (LVH)",
        "CXR (post-stenotic dilation)",
        "BNP in advanced disease prognostication"
      ],
      "management": [
        "Definitive treatment: aortic valve replacement (surgical or balloon valvotomy)",
        "Medical therapy does not halt progression; manage comorbidities (HTN, lipids)",
        "Symptomatic severe AS or LVEF <50%: valve replacement (SAVR or TAVR)",
        "Asymptomatic severe AS with very severe Vmax, rapid progression, or abnormal exercise test: consider intervention",
        "Cardiology/heart-team evaluation for TAVR vs SAVR based on age, anatomy, surgical risk"
      ],
      "pearls": [
        "Use vasodilators cautiously; avoid precipitous BP drops",
        "Use with caution if preload dependent; monitor for hypotension",
        "Echo surveillance: mild q3–5y, moderate q1–2y, severe q6–12mo or sooner if symptoms change",
        "Educate on red-flag symptoms (syncope, angina, dyspnea) and prompt evaluation",
        "Endocarditis prophylaxis only for high-risk prosthetic valve patients",
        "TAVR Post-Operative Care by NP: Valve types (Edwards Sapien S3, Medtronic CoreValve)",
        "Monitoring: Groin sites, peripheral pulses, EKG for LBBB/heart block",
        "If new LBBB: monitor with PPM inpatient; if heart block develops, permanent pacemaker may be required",
        "ECHO Post-Op: perform day 1; discharge after echo if no valve dysfunction (perivalvular leak or pericardial effusion)",
        "Follow-up: If new LBBB, monitor with 2-week preventive device"
      ]
    },
    {
      "id": "afib",
      "name": "Atrial Fibrillation / Flutter",
      "description": "Most common cardiac arrhythmia characterized by irregular atrial activation and ineffective atrial contraction, leading to increased stroke risk due to thrombus formation from stagnant blood.",
      "features": [
        "Palpitations (most common symptom)",
        "Shortness of breath",
        "Chest pain",
        "Fatigue",
        "Dizziness or syncope",
        "Asymptomatic in up to 30% of patients",
        "Atrial flutter: Regular atrial rate (~300 bpm) with saw-tooth P waves, variable ventricular response",
        "Atrial fibrillation: Irregularly irregular rhythm, absent P waves, chaotic atrial activity",
        "Thrombus formation risk increases after 48 hours of AF duration"
      ],
      "workup": [
        "ECG: Definitive diagnostic test [WHY: Confirms rhythm diagnosis and guides treatment urgency]",
        "AF: Irregularly irregular rhythm, absent P waves, chaotic baseline",
        "AFlutter: Regular rhythm with saw-tooth pattern (~300 bpm atrial rate)",
        "QRS width helps select antiarrhythmics (avoid class IC if wide)",
        "Echocardiogram (TTE): Obtain once rate controlled [WHY: Assesses structural heart disease, guides treatment selection]",
        "LA size predicts success of rhythm control (>4.5cm less likely to maintain SR)",
        "LV function guides medication choice (avoid class IC if EF <40%)",
        "Valve disease may be cause (mitral stenosis → AF)",
        "Electrolytes and metabolic panel [WHY: Identifies reversible triggers that can terminate AF when corrected]",
        "K+ <3.5 or Mg++ <1.7: Promote arrhythmias, correct before antiarrhythmics",
        "TSH: Hyperthyroidism causes AF in 10-15% of patients",
        "BMP: Kidney function guides anticoagulant dosing",
        "CHADS₂-VASc score calculation [WHY: Quantifies stroke risk to guide anticoagulation decision]",
        "Score ≥2: Anticoagulation reduces stroke risk by ~60%",
        "Score 0 (men) or 1 (women): No anticoagulation needed",
        "HAS-BLED score for bleeding risk [WHY: Balances stroke prevention benefit vs bleeding risk - score ≥3 indicates increased bleeding risk]",
        "TEE if cardioversion planned and AF >48h or unknown duration [WHY: Excludes LA appendage thrombus before cardioversion - AF >48h = high thrombus risk]",
        "Holter monitor or event recorder for paroxysmal AF [WHY: Documents arrhythmia burden and symptoms correlation - paroxysmal AF may be missed on single ECG]",
        "Sleep study if sleep apnea suspected [WHY: OSA increases AF recurrence; CPAP reduces AF burden - treat OSA before ablation procedures for better outcomes]"
      ],
      "management": [
        "Unstable patients (hypotension, ischemia, HF): Immediate synchronized cardioversion (200J → 300J → 360J)",
        "AF <48h: Rate or rhythm control without anticoagulation (low thrombus risk)",
        "AF >48h or unknown duration: Anticoagulation required before cardioversion",
        "Rate control: Beta-blockers (metoprolol, atenolol) or non-DHP CCBs (diltiazem, verapamil)",
        "Rhythm control: Amiodarone, flecainide, propafenone, sotalol (if no structural heart disease)",
        "Digoxin: Acceptable if systolic dysfunction or hypotension limits other agents",
        "Anticoagulation: DOACs preferred (apixaban, rivaroxaban, dabigatran) over warfarin",
        "CHADS₂-VASc ≥2 (men) or ≥3 (women): Oral anticoagulation recommended",
        "CHADS₂-VASc 0-1: Individualized decision based on risk factors",
        "Pre-cardioversion: Anticoagulate 3-4 weeks before OR TEE-guided approach",
        "Post-cardioversion: Continue anticoagulation 4 weeks minimum",
        "Lifestyle modifications: Weight loss, exercise, alcohol moderation, sleep hygiene",
        "Catheter ablation for symptomatic refractory AF"
      ],
      "pearls": [
        "CHADS₂-VASc Score: CHF(1), HTN(1), Age≥75(2), DM(1), Stroke/TIA(2), Vascular disease(1), Age 65-74(1), Sex female(1)",
        "CHADS₂-VASc ≥2: Anticoagulation recommended; 0-1: Consider anticoagulation",
        "Rate control goals: Symptomatic <85 bpm, Asymptomatic <110 bpm",
        "Beta-blockers first-line for rate control unless contraindicated",
        "Amiodarone first-line for post-CABG AF or hemodynamically unstable",
        "Digoxin requires K+ >4.0, renal dosing, careful monitoring",
        "Cardioversion contraindicated with atrial thrombus, unstable angina, electrolyte abnormalities",
        "Long-term anticoagulation may be required if thrombus risk persists",
        "Cardiology EP follow-up for rhythm monitoring and ablation evaluation",
        "Address modifiable risk factors: obesity, OSA, hypertension, alcohol",
        "Patient education: Medication adherence, symptom recognition, when to seek care"
      ],
      "clinical_triggers": {
        "symptoms_any": [
          "Palpitations",
          "Dyspnea",
          "Fatigue",
          "Chest discomfort",
          "Dizziness/syncope"
        ],
        "signs_any": [
          "Irregularly irregular pulse",
          "Tachycardia",
          "Variable BP"
        ]
      },
      "contraindications": {
        "non_dhp_ccb": ["Avoid in HFrEF with decompensation"],
        "class_ic": ["Avoid in structural heart disease or CAD (proarrhythmia)"]
      },
      "discharge": {
        "instructions": [
          "Stroke prevention plan documented (OAC if indicated)",
          "Education on rate/rhythm meds and when to seek care (worsening palpitations, syncope, chest pain)"
        ],
        "follow_up": [
          "Cardiology EP follow‑up; consider sleep apnea evaluation and risk factor modification (weight loss, ETOH moderation)"
        ]
      }
    },
    {
      "id": "atrial_flutter",
      "name": "Atrial Flutter",
      "description": "A type of supraventricular tachycardia resulting from a reentrant circuit in the right atrium.",
      "features": [
        "Palpitations",
        "Fatigue",
        "Dyspnea",
        "Chest discomfort",
        "Syncope (rare)"
      ],
      "workup": [
        "12-lead ECG (diagnosis)",
        "Telemetry/monitoring",
        "Echo (assess structural disease, LA size, LV function)",
        "Labs: thyroid, electrolytes"
      ],
      "management": [
        "Rate control with β-blocker or nondihydropyridine CCB",
        "Anticoagulation if duration >48h or unknown",
        "Electrical cardioversion if unstable or refractory",
        "Catheter ablation (cavotricuspid isthmus ablation) — high success, first-line definitive therapy",
        "Ongoing anticoagulation guided by CHA₂DS₂-VASc",
        "Rate vs rhythm strategy individualized"
      ],
      "pearls": [
        "Adherence to anticoagulation if indicated",
        "Monitor for recurrent palpitations",
        "Lifestyle: reduce alcohol, caffeine, stimulants",
        "Cardiology/EP follow-up, especially if considering ablation"
      ]
    },
    {
      "id": "asd",
      "name": "Atrial Septal Defect (ASD)",
      "description": "A congenital heart defect characterized by a direct connection between both atria through a defect in the septum. More common in women.",
      "features": [
        "Often asymptomatic in childhood",
        "Progressive dyspnea on exertion",
        "Fatigue and reduced exercise tolerance",
        "Palpitations from atrial arrhythmias",
        "Heart failure symptoms in adulthood",
        "Pulmonary hypertension (Eisenmenger syndrome)",
        "Recurrent respiratory infections",
        "Physical exam: systolic ejection murmur with fixed wide splitting of S2",
        "Best heard at left upper sternal border (pulmonic area)",
        "Risk for paradoxical emboli leading to stroke"
      ],
      "workup": [
        "Echocardiogram (TEE > TTE): best diagnostic test",
        "Bubble study with saline: confirms diagnosis (bubbles pass through defect)",
        "ECG: RBBB, RVH, right axis deviation",
        "Chest X-ray: cardiomegaly, enlarged RA/RV, prominent pulmonary artery",
        "Cardiac catheterization: more invasive, not routinely necessary",
        "Genetic testing: consider for associated syndromes"
      ],
      "management": [
        "Percutaneous device closure: preferred for secundum ASD if suitable anatomy",
        "Surgical closure: for primum ASD, sinus venosus defect, or unsuitable anatomy",
        "Medical management: diuretics for heart failure, anticoagulation for AF",
        "Anticoagulation: for AF or history of paradoxical embolus",
        "Pulmonary hypertension management if present",
        "Endocarditis prophylaxis: 6 months post-closure, then discontinue",
        "Lifestyle modifications: exercise as tolerated, avoid dehydration"
      ],
      "pearls": [
        "Three types: Primum (associated with anterior mitral valve cleft and MR), Secundum (most common), Sinus venosus (least common)",
        "PFO is not true ASD (no septal tissue missing, flap-like opening)",
        "Qp:Qs ratio >1.5 indicates significant shunt requiring closure",
        "Monitor for AF, RV dysfunction, pulmonary hypertension in adulthood",
        "Paradoxical emboli risk: consider closure if history of CVA/TIA",
        "Serial echocardiograms to monitor shunt magnitude and RV function",
        "Pregnancy generally well-tolerated but requires monitoring",
        "Report new palpitations, syncope, dyspnea, or edema",
        "Lifelong cardiology follow-up, especially if repaired in adulthood"
      ]
    },
    {
      "id": "bradyarrhythmia",
      "name": "Bradyarrhythmias (Sinus Node Dysfunction & AV Block)",
      "description": "Abnormally slow heart rate due to impaired electrical conduction, including various degrees of heart block.",
      "features": [
        "Syncope",
        "Presyncope",
        "Fatigue",
        "Dyspnea",
        "Exercise intolerance",
        "Dizziness",
        "Chest pain (if ischemic)",
        "Heart block symptoms vary by type and severity"
      ],
      "workup": [
        "12-lead ECG to identify block type [WHY: Determines block severity and urgency - 3rd degree requires immediate pacing, others may be observed]:",
        "First Degree: PR interval >0.20 sec, all P waves conducted",
        "Mobitz I (Wenckebach): PR interval progressively lengthens until dropped beat",
        "Mobitz II: Dropped QRS without PR lengthening",
        "Third Degree: Atria and ventricles beat independently, no conduction",
        "Telemetry/Holter monitor for intermittent symptoms [WHY: Captures intermittent high-grade blocks that may be missed on single ECG, correlates symptoms with rhythm]",
        "Labs (TSH, electrolytes, drug levels e.g. digoxin, beta-blockers) [WHY: Identifies reversible causes - hypothyroidism, hyperkalemia, drug toxicity can cause bradycardia]",
        "Echo if structural disease suspected [WHY: Structural heart disease may cause conduction system fibrosis, affects pacemaker selection and prognosis]",
        "Exercise testing if symptoms with exertion [WHY: Chronotropic incompetence suggests sinus node dysfunction, helps determine need for rate-responsive pacing]",
        "Electrophysiology study if diagnosis unclear [WHY: Measures conduction intervals, predicts progression to higher-grade blocks, guides pacing decisions]"
      ],
      "management": [
        "First Degree AV Block: No treatment (asymptomatic)",
        "Mobitz I (Wenckebach): No treatment if asymptomatic; pacemaker if unstable; atropine if severe",
        "Mobitz II: Consider pacemaker (progression to 3rd degree likely)",
        "Third Degree AV Block: Pacemaker required (may be fatal without)",
        "Atropine IV for symptomatic bradycardia",
        "Temporary pacing if refractory to atropine",
        "Treat reversible causes (ischemia, medications, hypothyroidism)",
        "Permanent pacemaker for symptomatic sinus node dysfunction",
        "Pacemaker for Mobitz II or complete heart block regardless of symptoms"
      ],
      "pearls": [
        "No pacing for asymptomatic sinus bradycardia or Mobitz I",
        "Mobitz II and 3rd degree blocks often require permanent pacing",
        "Progressive PR prolongation in Mobitz I vs constant PR in Mobitz II",
        "Third degree block: Independent atrial and ventricular rates",
        "Pacemaker clinic follow-up if implanted",
        "Monitor for progression in conduction disease",
        "Review medications that may worsen conduction (beta-blockers, CCBs, digoxin)",
        "Cardiology/EP follow-up for ongoing management",
        "Driving restrictions may apply with symptomatic bradycardia"
      ]
    },
    {
      "id": "cardiac_arrest",
      "name": "Cardiac Arrest / Sudden Cardiac Death",
      "description": "Sudden cessation of cardiac function, leading to unresponsiveness and absence of breathing.",
      "features": ["Collapse", "Unresponsiveness"],
      "workup": [
        "Immediate ACLS protocol [WHY: Time-critical emergency - brain death occurs within 4-6 minutes without circulation, immediate intervention is life-saving]",
        "ECG rhythm identification (VF, pulseless VT, PEA, asystole) [WHY: Determines treatment approach - shockable rhythms (VF/VT) get immediate defibrillation, non-shockable get CPR + epinephrine]"
      ],
      "management": [
        "Immediate defibrillation",
        "CPR, epinephrine every 3–5 min, amiodarone",
        "PEA, asystole: CPR, epinephrine, treat reversible causes (Hs & Ts)",
        "Post-ROSC: Targeted temperature management, Coronary angiography if STEMI, ICU care"
      ],
      "pearls": [
        "Family counseling, ICD consideration if appropriate",
        "Cardiology, EP"
      ]
    },
    {
      "id": "cardiogenic_shock",
      "name": "Cardiogenic Shock",
      "description": "Inadequate cardiac output with tissue hypoperfusion despite adequate preload. Most common cause is acute MI.",
      "features": [
        "Hemodynamic criteria: CI <2.2 L/min/m², PCWP >15 mmHg, SBP <90 or MAP <65 mmHg",
        "Cool, clammy extremities (↓CO → compensatory ↑SVR → vasoconstriction)",
        "Reflex tachycardia (except AV blocks, β-blocker overdose)",
        "Altered mental status, oliguria (<0.5 mL/kg/hr)",
        "Pulmonary congestion if LV failure (rales, S3 gallop, JVD)",
        "Mechanical causes: MI, heart failure (HFrEF), valvular damage (acute MR/AR)",
        "Arrhythmogenic causes: V-Tac, V-Fib, A-Fib, SVT, AV blocks"
      ],
      "workup": [
        "ECG: Acute ST changes, arrhythmias, conduction abnormalities",
        "Echocardiogram: Wall motion abnormalities, valve function, LVEF assessment",
        "Cardiac enzymes: Troponin elevation (assess for acute MI)",
        "Chest X-ray: Pulmonary edema, cardiomegaly",
        "Swan-Ganz catheter: ↑CVP (>15 mmHg), ↑PCWP (>18 mmHg), ↓CI, ↑SVR, ↓SvO2",
        "Lactate levels: >2 mmol/L indicates tissue hypoperfusion",
        "Shock severity: Mild (CI 1.8-2.2), Moderate (CI 1.5-1.8), Severe (CI <1.5)"
      ],
      "management": [
        "Immediate: ABC assessment, oxygen, central venous and arterial access",
        "Inotropes (first-line): Dobutamine 5-20 μg/kg/min, Milrinone 0.25-0.75 μg/kg/min",
        "Vasopressors if hypotensive: Norepinephrine 0.1-2 μg/kg/min, Epinephrine 0.1-1 μg/kg/min",
        "Mechanical support: IABP (↑diastolic pressure, ↓afterload), Impella, VA-ECMO",
        "Treat underlying cause: Emergent PCI (MI), cardioversion (arrhythmias), valve repair",
        "Supportive: Cautious fluids, diuretics for congestion, anticoagulation",
        "Monitoring: Continuous hemodynamics, serial echos, watch for complications"
      ],
      "pearls": [
        "IABP contraindications: Severe AR, aortic dissection, severe PAD",
        "Inotrope contraindications: HOCM, severe AS, uncontrolled tachyarrhythmias",
        "ECMO contraindications: Irreversible multiorgan failure, active bleeding",
        "Early mechanical support improves outcomes in severe cases",
        "Avoid excessive fluid administration (worsens pulmonary edema)",
        "Documentation: 'Shock index 1.2 (elevated), lactate 3.8 mmol/L (tissue hypoperfusion)'"
      ]
    },
    {
      "id": "cvi",
      "name": "Chronic Venous Insufficiency / Varicose Veins",
      "description": "Inadequate venous return over a prolonged period, leading to varicosities and venous stasis.",
      "features": [
        "Leg heaviness/aching",
        "Swelling worse with standing",
        "Itching",
        "Varicose veins",
        "Skin changes (hyperpigmentation, lipodermatosclerosis)",
        "Ulceration (advanced)"
      ],
      "workup": ["Duplex venous ultrasound (reflux, obstruction)"],
      "management": [
        "Compression stockings",
        "Leg elevation, exercise, weight management",
        "Skin care for stasis dermatitis",
        "Endovenous ablation (laser, radiofrequency)",
        "Sclerotherapy",
        "Surgical vein stripping for severe/refractory disease"
      ],
      "pearls": [
        "Daily use of compression stockings",
        "Regular ambulation, avoid prolonged standing",
        "Skin care with emollients, wound care if ulcers",
        "Vascular follow-up; wound care clinic if ulcers present"
      ]
    },
    {
      "id": "coarctation_aorta",
      "name": "Coarctation of the Aorta",
      "description": "A congenital narrowing of the descending aorta at the insertion of the ductus arteriosus, just distal to the left subclavian artery, causing obstruction and increased left ventricular afterload.",
      "features": [
        "Hypertension in upper extremities",
        "Reduced blood pressure and diminished pulses in lower extremities",
        "Respiratory distress in newborns",
        "Heart failure symptoms",
        "Differential cyanosis (pink upper body, blue lower body)",
        "Weak femoral pulses compared to brachial pulses",
        "Headache, epistaxis from hypertension",
        "Leg claudication with exercise"
      ],
      "workup": [
        "Echocardiogram: diagnostic test of choice, shows narrowing and collateral vessels",
        "ECG: LVH from pressure overload",
        "Chest X-ray: rib notching (erosion of ribs from collateral circulation), '3' sign (dilation of aortic notch)",
        "CTA/MRA: most accurate for anatomy and collaterals",
        "Cardiac catheterization: for intervention if needed"
      ],
      "management": [
        "Surgical correction: preferred method (resection with end-to-end anastomosis)",
        "Balloon angioplasty: for recurrent coarctation",
        "Stent placement: for older patients or recurrent cases",
        "Medical management: antihypertensives for hypertension",
        "Endocarditis prophylaxis: if prosthetic material used",
        "Monitor for aortic aneurysm at repair site"
      ],
      "pearls": [
        "Associated with bicuspid aortic valve in 50-70% of cases",
        "Critical coarctation presents in newborn period with shock",
        "Serial blood pressure measurements in all extremities",
        "Monitor for rebound hypertension post-repair",
        "Risk of aortic dissection or aneurysm at repair site",
        "Associated with Turner syndrome, genetic counseling recommended",
        "Report hypertension, headache, leg pain, or unequal pulses",
        "Lifelong cardiology follow-up",
        "Exercise restrictions may be needed based on residual gradient"
      ]
    },
    {
      "id": "cardiac_medications",
      "name": "Common Cardiac Medications & Dosages",
      "category": "Medications",
      "description": "Comprehensive reference for cardiac medication dosing, indications, and administration guidelines",
      "symptoms": [
        "Acute coronary syndromes requiring antiplatelet therapy",
        "Atrial fibrillation requiring anticoagulation",
        "Heart failure requiring beta-blockers and ACE inhibitors",
        "Hypertension management",
        "Arrhythmia control with antiarrhythmics",
        "Angina management with nitrates and antianginals"
      ],
      "examination": [
        "Blood pressure assessment for medication titration",
        "Heart rate and rhythm evaluation",
        "Signs of heart failure (edema, JVD)",
        "Medication adherence assessment",
        "Adverse effect monitoring"
      ],
      "workup": [
        "Renal function assessment (CrCl, eGFR)",
        "Liver function tests",
        "Electrolyte monitoring (K+, Mg++)",
        "ECG monitoring for QT interval",
        "INR monitoring for warfarin",
        "Drug level monitoring (digoxin)"
      ],
      "diagnosis": [
        "Indication-appropriate medication selection",
        "Contraindication assessment",
        "Drug interaction evaluation",
        "Dosing adjustment for comorbidities",
        "Therapeutic drug monitoring"
      ],
      "management": [
        "Antiplatelets:",
        "• Aspirin: 81–325 mg PO daily",
        "• Clopidogrel (Plavix): 75 mg PO daily (after 300–600 mg loading dose)",
        "• Ticagrelor (Brilinta): 90 mg PO BID (after 180 mg loading dose)",
        "• Prasugrel (Effient): 10 mg PO daily (after 60 mg loading dose)",
        "",
        "Anticoagulants:",
        "• Warfarin (Coumadin): 2–5 mg PO daily, titrated to INR (goal 2–3 for most indications)",
        "• Apixaban (Eliquis): 5 mg PO BID (2.5 mg BID if ≥80 yrs, ≤60 kg, or Cr ≥1.5)",
        "• Rivaroxaban (Xarelto): 20 mg PO daily with food (15 mg daily if CrCl 15–50)",
        "• Dabigatran (Pradaxa): 150 mg PO BID (75 mg BID if CrCl 15–30)",
        "• Enoxaparin (Lovenox): 1 mg/kg SQ q12h (1.5 mg/kg daily if normal renal, adjust if CrCl <30)",
        "",
        "Beta Blockers:",
        "• Metoprolol Tartrate (Lopressor): 25–50 mg PO BID (IV 5 mg q5min ×3 if ACS)",
        "• Metoprolol Succinate (Toprol-XL): 25–200 mg PO daily (CHF start 12.5–25 mg daily)",
        "• Carvedilol (Coreg): 3.125 mg PO BID → titrate to 25–50 mg BID",
        "• Bisoprolol (Zebeta): 2.5–10 mg PO daily",
        "• Atenolol (Tenormin): 25–100 mg PO daily",
        "",
        "ACE Inhibitors / ARBs / ARNI:",
        "• Lisinopril: 2.5–40 mg PO daily",
        "• Enalapril: 2.5–20 mg PO BID",
        "• Losartan: 25–100 mg PO daily (often divided BID)",
        "• Valsartan: 80–320 mg PO daily (divided BID)",
        "• Sacubitril/Valsartan (Entresto): 24/26 mg PO BID → titrate to 97/103 mg BID",
        "",
        "Diuretics:",
        "• Furosemide (Lasix): 20–80 mg PO daily or BID (IV for acute use)",
        "• Bumetanide (Bumex): 0.5–2 mg PO or IV daily or BID",
        "• Torsemide (Demadex): 10–40 mg PO daily",
        "• Hydrochlorothiazide (HCTZ): 12.5–50 mg PO daily",
        "• Spironolactone (Aldactone): 25–50 mg PO daily (CHF start 12.5–25 mg)",
        "• Eplerenone (Inspra): 25–50 mg PO daily",
        "",
        "Statins:",
        "• Atorvastatin (Lipitor): 10–80 mg PO daily",
        "• Rosuvastatin (Crestor): 5–40 mg PO daily",
        "• Simvastatin (Zocor): 10–40 mg PO daily (not >20 mg with amlodipine)",
        "• Pravastatin (Pravachol): 10–80 mg PO daily",
        "",
        "Nitrates & Antianginals:",
        "• Nitroglycerin SL (Nitrostat): 0.3–0.6 mg SL q5min ×3 max for acute angina",
        "• Nitroglycerin Patch (Nitro-Dur): 0.2–0.8 mg/hr, applied 12–14 hr/day",
        "• Isosorbide Mononitrate (Imdur): 30–60 mg PO daily (max 240 mg)",
        "• Ranolazine (Ranexa): 500 mg PO BID → titrate to 1000 mg PO BID",
        "",
        "Antiarrhythmics:",
        "• Amiodarone: IV load: 150 mg over 10 min → 1 mg/min ×6h → 0.5 mg/min ×18h",
        "• Amiodarone: PO: 800–1600 mg daily ×1–3 weeks, then 200–400 mg daily maintenance",
        "• Sotalol: 80–160 mg PO BID (adjust for renal)",
        "• Dofetilide (Tikosyn): 125–500 mcg PO BID (hospital initiation with QT monitoring)",
        "• Digoxin: 0.125–0.25 mg PO/IV daily (lower in elderly/renal impairment)"
      ],
      "pearls": [
        "Start beta-blockers at low doses and titrate slowly, especially in heart failure patients",
        "Monitor renal function and potassium when using ACE inhibitors and ARBs",
        "Warfarin requires frequent INR monitoring and dose adjustments",
        "DOAC dosing must be adjusted for renal function and weight",
        "Amiodarone requires monitoring of thyroid, liver, and pulmonary function",
        "Statins should be dosed in the evening for optimal LDL reduction",
        "Diuretics can cause electrolyte imbalances requiring monitoring",
        "Nitroglycerin patches should have a nitrate-free interval to prevent tolerance",
        "Antiplatelet therapy duration depends on clinical indication and stent type",
        "Beta-blockers should not be abruptly discontinued due to rebound hypertension",
        "ACE inhibitors are contraindicated in pregnancy and bilateral renal artery stenosis",
        "Spironolactone requires potassium monitoring due to hyperkalemia risk",
        "Dofetilide initiation requires inpatient telemetry monitoring",
        "Digoxin has a narrow therapeutic index requiring level monitoring",
        "Consider drug interactions when combining cardiac medications"
      ]
    },
    {
      "id": "chf",
      "name": "Congestive Heart Failure (CHF)",
      "description": "A pump problem causing decreased perfusion to tissues and underoxygenation, due to filling problems (diastolic dysfunction) or pumping problems (systolic dysfunction).",
      "features": [
        "Most common symptoms: fatigue and shortness of breath",
        "Left-sided HF: crackles, orthopnea, paroxysmal nocturnal dyspnea",
        "Right-sided HF: jugular venous distension, hepatojugular reflex, pedal edema, ascites",
        "Acute exacerbation: pulmonary edema, orthopnea, PND",
        "Chronic symptoms: exercise intolerance, weight gain, abdominal discomfort"
      ],
      "workup": [
        "Echocardiogram: most useful test [WHY: Determines EF (systolic vs diastolic HF), assesses wall motion, valve function, guides therapy]",
        "EF <40% = HFrEF (systolic dysfunction) → ACEi/ARB + beta-blocker mortality benefit",
        "EF ≥50% = HFpEF (diastolic dysfunction) → symptom management, treat comorbidities",
        "ECG: Always obtain [WHY: Identifies ischemia (treatable cause), arrhythmias (AF common in HF), conduction delays]",
        "Q waves suggest old infarct (ischemic cardiomyopathy)",
        "LBBB + EF ≤35% + QRS ≥150ms = candidate for CRT device",
        "Chest X-ray: Essential for dyspnea evaluation [WHY: Confirms pulmonary congestion vs other causes, monitors treatment response]",
        "Findings: cardiomegaly, cephalization, Kerley B lines, pleural effusions",
        "BNP/NT-proBNP: Key diagnostic test [WHY: Differentiates heart failure from other dyspnea causes (COPD, pneumonia)]",
        "BNP >400 pg/mL suggests CHF, <100 pg/mL rules out CHF",
        "Trending levels guides diuretic therapy effectiveness",
        "Cardiac enzymes (troponin): Rule out acute MI [WHY: MI can precipitate HF exacerbation, changes treatment approach]",
        "Stress testing: Risk stratification [WHY: Assesses exercise capacity, detects ischemia as reversible cause]",
        "Laboratory panel: CBC, CMP, TSH, iron studies [WHY: Identifies precipitating factors and complications]",
        "Anemia worsens HF symptoms",
        "Kidney function guides medication dosing (ACEi/ARB/diuretics)",
        "Thyroid disease can cause or worsen HF",
        "Iron deficiency common in HF, impacts exercise tolerance",
        "Sleep study: Consider if OSA suspected [WHY: OSA worsens HF outcomes, CPAP therapy improves symptoms]"
      ],
      "management": [
        "Diastolic dysfunction: no proven mortality-reducing medications; focus on symptom management and comorbidities",
        "Systolic dysfunction: ACEi/ARB/ARNI and beta-blockers are main therapies (class effect on mortality)",
        "Never combine ACEi with ARB",
        "Acute exacerbation 'LMNOP': Loop diuretics, Morphine, Nitrates, Oxygen, Position (upright)",
        "Refractory cases: inotropes (milrinone, dobutamine) or mechanical support",
        "Device therapy: ICD for EF ≤35%, CRT for LBBB + QRS ≥150ms + EF ≤35%",
        "Advanced therapy: LVAD or heart transplant for refractory cases",
        "Mandatory discharge medications: ACEi/ARNI/ARB, beta-blocker, diuretic, MRA, nitrates"
      ],
      "pearls": [
        "Systolic dysfunction: EF <50%, decreased contractility; Diastolic dysfunction: normal/high EF, poor relaxation",
        "Systolic etiology: CAD, HTN, cardiomyopathy, valvular disease, diabetes",
        "Diastolic etiology: HTN, ischemia, age, cardiomyopathy, post-MI scarring",
        "Daily weights and low-sodium diet essential for monitoring",
        "Diuretic compliance critical - emphasize at every visit",
        "Accurate I/Os and volume status assessment",
        "Consider nephrology consult in advanced cardiorenal syndrome",
        "CXR prior to discharge to document improvement",
        "Early post-discharge follow-up within 7 days",
        "Vaccinations and guideline-directed preventive care"
      ],
      "pdfs": [
        {
          "title": "Congestive Heart Failure Clinical Notes",
          "path": "/src/assets/pdfs/cardiology/heart-failure/congestive-heart-failure-notes.pdf",
          "description": "Comprehensive guide to CHF pathophysiology, diagnosis, and management (6.6 MB)"
        },
        {
          "title": "Cardiomyopathy Clinical Notes",
          "path": "/src/assets/pdfs/cardiology/heart-failure/cardiomyopathy-notes.pdf",
          "description": "Comprehensive guide to cardiomyopathy types, diagnosis, and management (4.7 MB)"
        }
      ]
    },
    {
      "id": "constrictive_pericarditis",
      "name": "Constrictive Pericarditis",
      "description": "Scarring of the pericardium that leads to thickening and restricts diastolic filling. Most common causes are idiopathic and viral.",
      "features": [
        "Distended neck veins (systemic venous hypertension)",
        "Pericardial knock (abrupt cessation of ventricular filling)",
        "Kussmaul sign (jugular venous distension increases during inspiration)",
        "Ascites",
        "Edema",
        "Fatigue and weakness"
      ],
      "workup": [
        "EKG: nonspecific ST and T wave changes",
        "Chest X-ray: may show calcification",
        "Echocardiogram: pericardial thickening, decreased diastolic filling",
        "CT scan: pericardial thickening and/or calcification",
        "Cardiac catheterization: equalization of diastolic pressures"
      ],
      "management": [
        "Diuretics and pericardiectomy",
        "Treat underlying cause if identified",
        "Salt restriction and fluid management",
        "Surgical pericardiectomy for symptomatic patients"
      ],
      "pearls": [
        "Monitor for worsening right-sided HF symptoms",
        "Consider referral for surgical pericardiectomy evaluation",
        "Cardiology/surgical follow-up",
        "Differentiate from restrictive cardiomyopathy",
        "Pericardiectomy has high success rate when performed early",
        "Post-operative monitoring for recurrence"
      ]
    },
    {
      "id": "dvt",
      "name": "Deep Vein Thrombosis (DVT)",
      "description": "Formation of a blood clot in a deep vein, usually in the legs, arising from Virchow's triad: hypercoagulability, stasis, and endothelial injury.",
      "features": [
        "Unilateral lower extremity pain, erythema, swelling",
        "Homan's sign (pain with dorsiflexion of ankle) - not sensitive/specific but may appear on exams",
        "Warmth and tenderness along the vein",
        "Asymmetric leg swelling",
        "Pitting edema",
        "Collateral superficial veins visible"
      ],
      "workup": [
        "Modified Wells Criteria for pretest probability:",
        "  - Active cancer (1 point)",
        "  - Paralysis, paresis, immobilization of lower extremities (1 point)",
        "  - Recently bedridden >3 days or surgery within 4 weeks (1 point)",
        "  - Localized tenderness along distribution of deep veins (1 point)",
        "  - Entire leg swollen (1 point)",
        "  - Calf swelling ≥3 cm (1 point)",
        "  - Pitting edema (1 point)",
        "  - Collateral superficial veins (1 point)",
        "  - Previously documented DVT (1 point)",
        "  - Alternative diagnosis more likely than DVT (-2 points)",
        "Interpretation: Score ≤2 = low probability → order D-dimer; Score ≥2 = high probability → order duplex ultrasound",
        "D-dimer: Normal virtually excludes DVT; Elevated requires imaging",
        "Duplex ultrasound: Diagnostic test of choice",
        "Do not get D-dimer in high probability patients",
        "Do not screen for hypercoagulable states during initial workup"
      ],
      "management": [
        "Anticoagulation: Start immediately with heparin (unfractionated or LMWH), fondaparinux, or factor Xa inhibitors",
        "Direct oral anticoagulants (DOACs: rivaroxaban, apixaban, dabigatran, edoxaban) preferred for long-term",
        "Warfarin: Requires bridging with heparin until INR therapeutic (2-3); overlap for at least 5 days",
        "Pregnancy: Treat with LMWH, not warfarin (teratogenic)",
        "Duration: Minimum 3 months; Provoked DVT = 3-6 months; Cancer patients = lifelong",
        "Contraindications to anticoagulation: Consider IVC filter placement",
        "Compression stockings for symptom relief and post-thrombotic syndrome prevention",
        "Mobilization as tolerated with anticoagulation"
      ],
      "pearls": [
        "Risk factors: Hypercoagulability (OCP, pregnancy, cancer), Stasis (immobilization, travel), Endothelial injury (surgery, trauma)",
        "Age >65, obesity, prior DVT/PE additional risk factors",
        "Some patients have no identifiable risk factors (unprovoked DVT)",
        "Active bleeding or high bleeding risk: Consider IVC filter if acute proximal DVT",
        "Monitor for pulmonary embolism signs (dyspnea, chest pain, tachycardia)",
        "Medication adherence critical - emphasize compliance",
        "Report bleeding, bruising, shortness of breath, chest pain",
        "Follow-up with hematology/PCP for duration decisions",
        "Recurrence risk assessment for indefinite anticoagulation decisions"
      ]
    },
    {
      "id": "dcm",
      "name": "Dilated Cardiomyopathy (DCM)",
      "description": "Disease of the heart muscle causing ventricular dilation and systolic dysfunction, leading to heart failure.",
      "features": [
        "Progressive dyspnea on exertion",
        "Fatigue and weakness",
        "Orthopnea and paroxysmal nocturnal dyspnea",
        "Peripheral edema",
        "Abdominal distension (ascites)",
        "Weight gain",
        "Palpitations from arrhythmias",
        "Syncope or near-syncope",
        "Symptoms identical to congestive heart failure"
      ],
      "workup": [
        "Echocardiogram: Dilated ventricles, decreased EF (<40%), global hypokinesis [WHY: Confirms diagnosis, quantifies severity, guides ICD/CRT candidacy, monitors treatment response]",
        "ECG: Non-specific changes, arrhythmias, conduction abnormalities, LVH [WHY: LBBB with QRS ≥150ms indicates CRT candidacy, arrhythmias common in DCM]",
        "Chest X-ray: Cardiomegaly, pulmonary congestion, pleural effusions [WHY: Shows heart enlargement and fluid status, monitors treatment response]",
        "Cardiac MRI: Assess fibrosis, infiltrative disease, viability [WHY: Distinguishes ischemic vs non-ischemic etiology, detects infiltrative diseases, assesses viability for interventions]",
        "Labs: BNP/NT-proBNP elevated, troponin, TSH, iron studies, viral titers [WHY: BNP guides treatment, TSH/iron deficiency are reversible causes, viral titers may identify myocarditis]",
        "Genetic testing: Consider in familial cases [WHY: 20-35% of DCM is familial, affects family screening recommendations and prognosis]",
        "Endomyocardial biopsy: If infiltrative disease suspected [WHY: Identifies specific treatable causes like sarcoidosis, amyloidosis, hemochromatosis]",
        "Coronary angiography: Rule out ischemic etiology [WHY: Ischemic cardiomyopathy has different prognosis and treatment, revascularization may improve function]"
      ],
      "management": [
        "Guideline-directed medical therapy (GDMT): ACEI/ARB/ARNI, beta-blocker, MRA, SGLT2i",
        "Diuretics: Loop diuretics for volume overload (furosemide, bumetanide)",
        "Anticoagulation: For AF, thrombus, or EF <35%",
        "ICD: For secondary prevention or primary prevention if EF ≤35% after 3 months GDMT",
        "CRT: If EF ≤35% with LBBB and QRS ≥150ms",
        "Treat underlying causes: Alcohol cessation, thyroid replacement, chelation for hemochromatosis",
        "Lifestyle modifications: Sodium restriction, daily weights, exercise as tolerated",
        "Advanced therapies: LVAD, heart transplant for refractory cases",
        "Monitor for arrhythmias and sudden cardiac death risk"
      ],
      "pearls": [
        "Most common cardiomyopathy type",
        "Idiopathic etiology most common, ischemic second most common",
        "Serial echocardiograms to monitor EF and response to therapy",
        "Daily weights and low-sodium diet (<2g/day)",
        "ACEI/ARB/ARNI cornerstone of therapy - improve survival by 15-35%",
        "Beta-blockers reduce mortality by 35% in HFrEF",
        "MRA prevent potassium/magnesium wasting, reduce SCD",
        "SGLT2i reduce HF hospitalizations independent of diabetes",
        "ICD reduces SCD by 50-60% in appropriate patients",
        "Cardiology/HF clinic follow-up every 3-6 months",
        "Call for rapid weight gain (>2kg/week), worsening dyspnea, edema"
      ]
    },
    {
      "id": "dcm",
      "name": "Dilated Cardiomyopathy (DCM)",
      "description": "Primary myocardial disease characterized by dilated ventricles and impaired systolic function in the absence of abnormal loading conditions or coronary artery disease.",
      "features": [
        "Progressive dyspnea on exertion",
        "Fatigue and exercise intolerance",
        "Orthopnea and paroxysmal nocturnal dyspnea",
        "Peripheral edema and ascites",
        "Chest pain (atypical, non-ischemic)",
        "Palpitations and arrhythmias",
        "Syncope (advanced cases)"
      ],
      "clinical_triggers": {
        "symptoms_any": [
          "Progressive dyspnea",
          "Fatigue",
          "Orthopnea",
          "PND",
          "Edema"
        ],
        "signs_any": [
          "S3 gallop",
          "Displaced apical impulse",
          "Signs of HF (edema, JVD, rales)"
        ]
      },
      "workup": [
        "Echocardiogram: Key diagnostic test [WHY: Shows dilated LV, reduced EF (<40%), global hypokinesis, differentiates from ischemic cardiomyopathy]",
        "ECG: Often abnormal [WHY: Identifies arrhythmias (common complication), conduction abnormalities, helps guide device therapy]",
        "Findings: nonspecific ST-T changes, left bundle branch block, atrial fibrillation",
        "Chest X-ray: Shows cardiomegaly and pulmonary congestion [WHY: Confirms heart failure, monitors treatment response]",
        "BNP/NT-proBNP: Elevated, correlates with severity [WHY: Confirms heart failure diagnosis, monitors treatment response]",
        "Cardiac catheterization: Rule out coronary disease [WHY: Distinguishes non-ischemic from ischemic cardiomyopathy, changes treatment approach]",
        "Cardiac MRI: Advanced imaging [WHY: Assesses for fibrosis, infiltrative disease, guides prognosis and therapy decisions]",
        "Laboratory studies: CBC, CMP, TSH, iron studies [WHY: Identifies reversible causes and comorbidities]",
        "Viral serologies and autoimmune workup: If indicated [WHY: Identifies treatable inflammatory causes]",
        "Genetic testing: Consider if family history [WHY: Identifies inherited forms, guides family screening]",
        "Endomyocardial biopsy: Rarely needed [WHY: Reserved for suspected infiltrative disease or giant cell myocarditis]"
      ],
      "management": [
        "Heart failure medications (4-pillar therapy): ARNI/ACEi/ARB, β-blocker, MRA, SGLT2 inhibitor",
        "Diuretics: For volume overload symptoms [WHY: Improves symptoms and functional capacity]",
        "ICD therapy: Consider if EF ≤35% after 3 months optimal medical therapy [WHY: Prevents sudden cardiac death]",
        "CRT therapy: If EF ≤35%, LBBB, QRS ≥150 ms [WHY: Improves symptoms, functional status, and mortality]",
        "Anticoagulation: If atrial fibrillation or LV thrombus [WHY: Prevents thromboembolic complications]",
        "Treat underlying causes: Alcohol cessation, thyroid optimization, nutritional deficiencies",
        "Advanced therapies: LVAD, heart transplant for refractory Stage D heart failure",
        "Lifestyle modifications: Low sodium diet, fluid restriction, daily weights, exercise as tolerated"
      ],
      "pearls": [
        "Most common cause of heart failure in young adults",
        "Can be familial (30-40% of cases) - screen family members with echo/ECG",
        "Alcohol-induced cardiomyopathy can improve with complete abstinence",
        "Peripartum cardiomyopathy occurs in last month of pregnancy to 5 months postpartum",
        "Sudden cardiac death risk highest in younger patients and those with ventricular arrhythmias",
        "Recovery of LV function possible in 10-40% of cases, especially with recent onset",
        "Consider heart transplant evaluation early in young patients with refractory symptoms",
        "Avoid pregnancy until LV function recovers due to high maternal mortality risk",
        "Annual influenza and pneumococcal vaccination recommended"
      ],
      "pdfs": [
        {
          "title": "Cardiomyopathy Clinical Notes",
          "path": "/src/assets/pdfs/cardiology/heart-failure/cardiomyopathy-notes.pdf",
          "description": "Comprehensive guide to cardiomyopathy types, diagnosis, and management (4.7 MB)"
        }
      ]
    },
    {
      "id": "distributive_shock",
      "name": "Distributive Shock",
      "description": "Shock due to massive vasodilation with decreased SVR. ONLY shock type with ↓↓SVR.",
      "features": [
        "Pathophysiology: ↑↑Vasodilation → ↓↓SVR → ↓BP and ↓MAP → ↓Organ perfusion",
        "Warm, pink/red extremities (well-perfused, not mottled)",
        "Reflex tachycardia (except neurogenic shock)",
        "Swan-Ganz findings: ↓CVP, ↓PCWP, ↑CI (>3.0), ↓↓SVR (<800), ↑SvO2 (>70%)",
        "Neurogenic: Spinal cord injury → ↓sympathetic tone → hypotension + bradycardia",
        "Septic: Systemic infection → ↑cytokines (IL-1, TNF-α) → inflammation + vasodilation",
        "Anaphylactic: Allergic reaction → ↑histamine/leukotrienes → vasodilation + capillary leak"
      ],
      "workup": [
        "Neurogenic: Neurologic exam, spinal imaging, assess for trauma",
        "Septic: Blood cultures, urinalysis, chest X-ray, procalcitonin, source identification",
        "Anaphylactic: History of allergen exposure, elevated tryptase levels",
        "SIRS criteria (sepsis): Temp >38°C or <36°C, HR >90, RR >20, WBC >12,000 or <4,000"
      ],
      "management": [
        "Neurogenic: Spinal immobilization, vasopressors (phenylephrine, norepinephrine), atropine for bradycardia",
        "Septic: 30 mL/kg IV fluid bolus + broad-spectrum antibiotics within 1 hour + source control",
        "Anaphylactic: STAT IM epinephrine 0.3-0.5 mg + H1/H2 antihistamines + steroids + airway management",
        "Vasopressors if MAP <65 mmHg: Norepinephrine (first-line), vasopressin, epinephrine",
        "Goal MAP ≥65 mmHg for adequate organ perfusion"
      ],
      "pearls": [
        "Distributive is ONLY shock with ↓↓SVR (others compensate with ↑SVR)",
        "Neurogenic + cardiogenic are ONLY shocks with hypotension + bradycardia",
        "Epinephrine contraindicated in cocaine intoxication",
        "Early antibiotics in sepsis critical (1-hour bundle)",
        "Documentation: 'Warm extremities consistent with distributive physiology'"
      ]
    },
    {
      "id": "ep_guidelines",
      "name": "Electrophysiology (EP) Guidelines",
      "category": "Procedures",
      "description": "Comprehensive guidelines for electrophysiology procedures including device implants, ablations, and perioperative management",
      "symptoms": [
        "Pre-operative evaluation for EP procedures",
        "Post-operative care following EP interventions",
        "Device implant preparation and recovery",
        "Antiarrhythmic medication management",
        "Anticoagulation management for EP procedures"
      ],
      "examination": [
        "Pre-procedure assessment including vital signs, ECG, and baseline rhythm",
        "Device interrogation for existing implants",
        "Physical examination of implant sites",
        "Assessment of anticoagulation status",
        "Evaluation of comorbidities affecting procedure"
      ],
      "workup": [
        "ECG: Baseline rhythm assessment",
        "CXR: Pre-procedure chest imaging",
        "Labs: CBC, BMP, coagulation studies",
        "Device interrogation if applicable",
        "TEE if indicated for LAA closure",
        "Cardiac imaging as indicated"
      ],
      "diagnosis": [
        "Pre-procedure clearance assessment",
        "Risk stratification for complications",
        "Anticoagulation management plan",
        "Device selection and programming",
        "Post-procedure monitoring requirements"
      ],
      "management": [
        "Amiodarone Loading Protocols:",
        "Oral loading: 800-1600mg daily divided doses for 1-2 weeks, then maintenance 200-400mg daily",
        "IV loading: 150mg over 10 minutes, then 1mg/min x 6 hours, then 0.5mg/min x 18 hours",
        "Monitoring: QTc, LFTs, TFTs weekly during loading, then monthly",
        "Interactions: Warfarin (increase INR), digoxin (increase levels), beta-blockers (bradycardia)",
        "",
        "Holding DOACs/Anti-Platelets for Implants:",
        "Apixaban (Eliquis): Hold 24-48 hours pre-op, restart 24 hours post-op",
        "Rivaroxaban (Xarelto): Hold 24-48 hours pre-op, restart 24 hours post-op",
        "Dabigatran (Pradaxa): Hold 24-48 hours pre-op (48-72 if CrCl <50), restart 24 hours post-op",
        "Edoxaban (Savaysa): Hold 24-48 hours pre-op, restart 24 hours post-op",
        "Warfarin: Hold 4-5 days pre-op, restart evening of procedure or next day",
        "Aspirin: Hold 5-7 days pre-op for high bleeding risk procedures",
        "Clopidogrel (Plavix): Hold 5-7 days pre-op",
        "Ticagrelor (Brilinta): Hold 5-7 days pre-op",
        "Prasugrel (Effient): Hold 7-10 days pre-op",
        "",
        "Pre-operative Implant Guidelines:",
        "NPO after midnight, clear liquids until 2 hours pre-op",
        "Hold ACEI/ARB on day of procedure",
        "Continue beta-blockers unless bradycardia",
        "Antibiotic prophylaxis 30-60 min pre-op (cefazolin 2g IV or vancomycin if PCN allergic)",
        "Sedation assessment and airway evaluation",
        "Pre-procedure device interrogation and programming",
        "Consent discussion including risks, benefits, alternatives",
        "",
        "Post-operative Implant Guidelines:",
        "Bed rest for 12-24 hours post-implant",
        "Arm immobilization for 24-48 hours (left-sided implants)",
        "Vital signs monitoring every 15-30 min for first 2 hours, then hourly",
        "Telemetry monitoring for 24-48 hours",
        "Pain management: acetaminophen, opioids if needed",
        "Anti-emetics as needed",
        "Early mobilization protocol starting 12-24 hours post-op",
        "",
        "Wound Care Instructions:",
        "Keep dressing dry and intact for 24-48 hours",
        "No showers for 48 hours, sponge baths only",
        "Inspect incision daily for signs of infection (redness, drainage, warmth)",
        "No heavy lifting >10 lbs or strenuous activity for 4-6 weeks",
        "No driving for 1 week (or longer if ICD implanted)",
        "Follow-up appointment in 1-2 weeks for wound check",
        "Report any fever >101.5°F, increased pain, or drainage immediately",
        "",
        "Post-operative Diagnostics:",
        "CXR: Post-procedure to confirm lead positions and rule out pneumothorax",
        "Device interrogation: Pre-discharge and at follow-up",
        "ECG: Post-procedure and before discharge",
        "Labs: CBC, BMP if indicated for bleeding or electrolyte abnormalities",
        "Holter monitor: If symptoms or arrhythmia concerns",
        "Echo: If new murmur or concern for tamponade",
        "Repeat device check: 1-2 weeks post-implant, then every 3-6 months",
        "",
        "Pacemaker Generator Selection Guidelines (AHA/ACC 1998):",
        "",
        "Single-Chamber Atrial Pacemaker:",
        "Sinus Node Dysfunction:",
        "• Appropriate if no suspected abnormality of AV conduction and no increased risk for future AV block",
        "• Maintenance of AV synchrony during pacing desired",
        "• Rate response available if desired",
        "AV Block: Not appropriate",
        "Neurally Mediated Syncope or Carotid Sinus Hypersensitivity: Not appropriate (unless AV block systematically excluded)",
        "",
        "Single-Chamber Ventricular Pacemaker:",
        "Sinus Node Dysfunction:",
        "• Maintenance of AV synchrony during pacing not necessary",
        "• Rate response available if desired",
        "AV Block:",
        "• Appropriate in chronic atrial fibrillation or other atrial tachycardia where maintenance of AV synchrony is unnecessary",
        "• Rate response available if desired",
        "Neurally Mediated Syncope or Carotid Sinus Hypersensitivity:",
        "• Appropriate in chronic atrial fibrillation or other atrial tachyarrhythmia",
        "• Rate response available if desired",
        "",
        "Dual-Chamber Pacemaker:",
        "Sinus Node Dysfunction:",
        "• AV synchrony during pacing desired",
        "• Suspected abnormality of AV conduction or increased risk for future AV block",
        "• Rate response available if desired",
        "AV Block:",
        "• AV synchrony during pacing desired",
        "• Atrial pacing desired",
        "• Rate response available if desired",
        "Neurally Mediated Syncope or Carotid Sinus Hypersensitivity:",
        "• Appropriate if sinus mechanism present",
        "• Rate response available if desired",
        "",
        "Single-Lead, Atrial-Sensing Ventricular Pacemaker:",
        "Sinus Node Dysfunction: Not appropriate",
        "AV Block:",
        "• Appropriate if normal sinus node function and no need for atrial pacing",
        "• Desire to limit number of pacemaker leads",
        "Neurally Mediated Syncope or Carotid Sinus Hypersensitivity: Not appropriate",
        "",
        "ICD Implementation Guidelines (AHA/ACC/HRS):",
        "",
        "Secondary Prevention:",
        "• Documented episodes of cardiac arrest due to VT/VF (not due to transient or reversible cause)",
        "• Documented sustained VT (either spontaneous or induced by EP), not associated with AMI, and not due to a transient or reversible cause",
        "",
        "Primary Prevention:",
        "• Documented familial or inherited conditions with high risk of life-threatening VT (e.g., Long QT Syndrome, Hypertrophic Cardiomyopathy)",
        "",
        "Ischemic Cardiomyopathy with the Following:",
        "• Prior MI > 40 days",
        "• Prior revascularization > 90 days (3 months) on medical therapy",
        "• LVEF ≤ 35%",
        "• VT/VF inducible and sustained at EP study",
        "",
        "Non-Ischemic Dilated Cardiomyopathy with All of the Following:",
        "• Documented duration > 3 months on medical therapy",
        "• NYHA Class II or III",
        "• LVEF ≤ 35%",
        "",
        "Severe CHF with All of the Following:",
        "• Meets coverage requirements for CRT",
        "• QRS > 140 ms",
        "• MI < 40 days",
        "",
        "Exclusion Criteria for ICD:",
        "• CABG or PCI < 90 days",
        "• NYHA Class IV who do not meet CRT requirements",
        "• Candidate for coronary revascularization",
        "• VT/VF or CHF due to reversible cause",
        "• No reasonable expectation of survival > 1 year with good functional status",
        "",
        "Class I Recommendation for CRT:",
        "• LVEF ≤ 35%",
        "• Dilated LV cavity with severe systolic dysfunction",
        "• Recurrent CHF (NYHA Class III or ambulatory Class IV) despite optimal therapy, > 3–9 months duration",
        "• QRS duration ≥ 140 ms (best responders: LBBB with QRS ≥ 150 ms)",
        "• Ventricular tachyarrhythmia (VT/VF)",
        "• Sinus rhythm with best response (AV synchrony and VV synchrony)",
        "",
        "QT Prolonging Medications:",
        "",
        "Antimicrobials:",
        "• Azanamycin, Azithromycin, Bactrim, Ciprofloxacin, Chloroquine, Clarithromycin",
        "• Erythromycin, Fluconazole, Gatifloxacin, Gemifloxacin, Halofantrine, Imipramine",
        "• Itraconazole, Ketoconazole, Levofloxacin, Moxifloxacin, Ofloxacin, Pentamidine",
        "• Ritonavir, Sparfloxacin, Telithromycin, Voriconazole",
        "",
        "Antidepressants:",
        "• Amitriptyline, Citalopram, Clomipramine, Desipramine, Doxepin, Escitalopram",
        "• Fluoxetine, Nortriptyline, Paroxetine, Protriptyline, Sertraline, Trazodone",
        "• Trimipramine, Venlafaxine",
        "",
        "Antiemetics:",
        "• Dolasetron, Domperidone, Droperidol, Granisetron, Ondansetron",
        "",
        "Antipsychotics:",
        "• Chlorpromazine, Clozapine, Haloperidol, Mesoridazine, Paliperidone, Pimozide",
        "• Quetiapine, Risperidone, Sertindole, Thioridazine, Ziprasidone",
        "",
        "Antiarrhythmics:",
        "• Amiodarone, Disopyramide, Dofetilide, Dronedarone, Flecainide, Ibutilide",
        "• Nicardipine, Procainamide, Quinidine, Sotalol",
        "",
        "Anticonvulsants:",
        "• Felbamate, Fosphenytoin, Phenytoin",
        "",
        "Other Drugs:",
        "• Alfuzosin, Astemizole, Amantadine, Bepridil, Cisapride, Diphenhydramine",
        "• Epirubicin, Famotidine, Fingolimod, Galantamine, Indapamide, Lapatinib",
        "• Levomethadyl, Lithium, Methadone, Moxifloxacin, Nilotinib, Octreotide",
        "• Oxytocin, Probucol, Ranolazine, Sunitinib, Tacrolimus, Tamoxifen",
        "• Terfenadine, Tizanidine, Vandetanib, Verdenafil",
        "",
        "Orthostatic Hypotension Therapy Options:",
        "",
        "Midodrine (Alpha-Adrenergic Agonist):",
        "• Dose: 10 mg TID (daytime hours, start 2.5 mg)",
        "• Dose Adjustments: Use caution in patients with renal impairment",
        "",
        "Droxidopa (Alpha-/Beta-Adrenergic Agonist):",
        "• Dose: 100 mg TID, uptitrated Q24–48h as needed (max 1,800 mg/day)",
        "• Dose Adjustments: None",
        "",
        "Fludrocortisone (Corticosteroid):",
        "• Dose: 0.1 mg daily to 0.3 mg daily; uptitrate weekly as needed (max 1 mg/day)",
        "• Dose Adjustments: Doses >0.3 mg/day may cause unwanted side effects",
        "",
        "Pyridostigmine (Acetylcholinesterase Inhibitor):",
        "• Dose: 60 mg TID daily",
        "• Dose Adjustments: Lower doses may be required in patients with renal disease",
        "",
        "Atomoxetine (Selective Norepinephrine Reuptake Inhibitor):",
        "• Dose: 18 mg daily",
        "• Dose Adjustments: Dose reduction required in hepatic impairment (Child-Pugh B/C)",
        "",
        "Pseudoephedrine (Alpha-/Beta-Adrenergic Agonist):",
        "• Dose: 30 mg daily",
        "• Dose Adjustments: None",
        "",
        "Octreotide (Somatostatin Analog):",
        "• Dose: 12.5–50 µg daily",
        "• Dose Adjustments: None",
        "",
        "LifeVest (Wearable Cardioverter Defibrillator) Indications:",
        "",
        "Primary Prevention:",
        "• LVEF ≤ 35% and MI, NICM, or other DCM (including during the 40-day ICD waiting period)",
        "",
        "Post-MI:",
        "• After recent MI (coverage during the 40-day ICD waiting period)",
        "",
        "LifeVest Considerations:",
        "",
        "Coverage Periods:",
        "• Before and after CABG or PTCA (coverage during the 90-day ICD waiting period)",
        "• Listed for cardiac transplant",
        "• Recently diagnosed nonischemic cardiomyopathy (coverage during the 3–9 month ICD waiting period)",
        "• NYHA Class IV heart failure",
        "",
        "Not appropriate for patients with terminal disease and life expectancy < 1 year",
        "",
        "Notes:",
        "• ICD indications when patient condition delays or prohibits ICD implantation",
        "• ICD explanation should be provided to the patient",
        "• LifeVest Order Form Link: LifeVest Order Form",
        "",
        "Angiogram / LHC / RHC (Before Sending Down to Cath Lab):",
        "",
        "Pre-Procedure Requirements:",
        "• NPO after midnight",
        "• Screen for iodine allergy",
        "• Labs: Creatinine, H&H",
        "• Assess if patient can safely lie flat (maintain oxygen saturation)",
        "• PT/INR or DOAC/NOAC (Eliquis, Pradaxa, Xarelto) - Typically held for 48 hours",
        "• Lovenox: held the morning of the procedure",
        "",
        "Iodine Allergy Prep (Day Before):",
        "• Benadryl 25 mg PO q6h × 3 doses (1800, 0000, 0600)",
        "• Pepcid 20 mg PO q6h × 3 doses (1800, 0000, 0600)",
        "• Prednisone 50 mg PO q6h × 3 doses (1800, 0000, 0600)",
        "",
        "Iodine Allergy Prep (Emergent/Stat):",
        "• Solumedrol 125 mg IV × 1",
        "• Pepcid 20 mg IV × 1",
        "• Benadryl 25 mg IVP × 1"
      ],
      "pearls": [
        "Individualize anticoagulation management based on thromboembolic risk vs bleeding risk",
        "Document all medication holds and resumption plans clearly",
        "Ensure proper antibiotic prophylaxis to prevent infection",
        "Early mobilization reduces DVT risk but must balance with bleeding risk",
        "Patient education is crucial for wound care and activity restrictions",
        "Close follow-up essential for device programming and monitoring",
        "Involve cardiology early for complex anticoagulation scenarios",
        "Consider bridging anticoagulation for high-risk patients when appropriate",
        "Pacemaker selection should prioritize AV synchrony when sinus node function is preserved",
        "Single-chamber ventricular pacing is appropriate when atrial fibrillation is present",
        "Dual-chamber pacing is preferred when AV conduction abnormalities are suspected",
        "Rate-responsive pacing should be considered for patients with chronotropic incompetence",
        "Minimize lead burden when possible while maintaining appropriate pacing functionality",
        "ICD therapy is indicated for both secondary and primary prevention of sudden cardiac death",
        "LVEF ≤ 35% is a key criterion for primary prevention ICD in both ischemic and non-ischemic cardiomyopathy",
        "Wait at least 40 days post-MI and 90 days post-revascularization before ICD implantation",
        "CRT is indicated when ICD criteria are met plus QRS ≥ 140ms and severe systolic dysfunction",
        "Consider genetic testing in patients with suspected inherited arrhythmia syndromes",
        "Regular device interrogation and optimization is essential for long-term ICD management",
        "QT prolonging medications significantly increase risk of torsades de pointes, especially when combined",
        "Monitor QTc interval regularly when starting or adjusting QT prolonging medications",
        "Avoid combining multiple QT prolonging medications when possible",
        "Consider drug-drug interactions that may potentiate QT prolongation",
        "Electrolyte abnormalities (hypokalemia, hypomagnesemia) increase QT prolongation risk",
        "Genetic factors (Long QT syndrome) may predispose to drug-induced QT prolongation",
        "Orthostatic hypotension often responds to volume expansion and vasopressor therapy",
        "Midodrine should be dosed during daytime hours to avoid supine hypertension",
        "Fludrocortisone requires careful monitoring for fluid retention and hypokalemia",
        "LifeVest provides temporary protection during ICD waiting periods or when permanent ICD is contraindicated",
        "Patient compliance and comfort are crucial for successful LifeVest therapy",
        "Consider underlying causes of orthostatic hypotension before initiating pharmacologic therapy",
        "LifeVest is particularly useful for patients awaiting cardiac transplant or with recent NICM diagnosis",
        "Comprehensive iodine allergy preparation reduces contrast reaction risk in cath lab procedures",
        "Anticoagulation management is critical for cath lab procedures to balance bleeding and thrombosis risk",
        "Patient positioning assessment prevents complications during prolonged cath lab procedures",
        "LifeVest order form and patient education are essential for successful wearable defibrillator therapy"
      ]
    },
    {
      "id": "documentation_guidelines",
      "name": "H&P and Consult Note Guidelines",
      "category": "Documentation",
      "description": "Comprehensive guidelines for cardiology history and physical examinations and consult note documentation",
      "symptoms": [
        "Standardized documentation for cardiology admissions",
        "Consultation documentation for cardiac conditions",
        "Comprehensive patient assessment and history taking",
        "Structured clinical note formatting"
      ],
      "examination": [
        "Chief complaint documentation standards",
        "History of present illness structure",
        "Review of systems organization",
        "Physical examination templates"
      ],
      "workup": [
        "Past medical and surgical history documentation",
        "Family and social history assessment",
        "Previous diagnostic studies review",
        "Medication reconciliation"
      ],
      "diagnosis": [
        "Impression and plan formulation",
        "Diagnostic findings interpretation",
        "Clinical condition assessment",
        "Documentation completeness evaluation"
      ],
      "management": [
        "Chief Complaint:",
        "• H&Ps on admitted patients: Shortness of Breath, Chest Pain, etc.",
        "• Consults: Reason for Consult: New Onset Atrial Fibrillation, Chest Pain, New Onset Heart Failure",
        "",
        "History of Present Illness Template:",
        "• [Patient Name] is a [age] year-old [gender] known to CIS, Dr. [Name].",
        "• Presented to ER on [date of admission] with complaints of [symptoms].",
        "• Symptom onset: [duration prior to admission].",
        "• Location: [location of pain/discomfort].",
        "• Character: [description, e.g., stabbing, squeezing].",
        "• Severity: [pain score/10].",
        "• Associated symptoms: [SOB, nausea, diaphoresis, etc.].",
        "• ER workup: [labs, EKG, imaging results].",
        "• Current status: [symptom progression, worsening or improving].",
        "• Admission reason: [diagnosis/findings, justification for admission].",
        "• Plan: [brief summary].",
        "",
        "Past Medical History:",
        "• List all past medical history",
        "",
        "Past Surgical History:",
        "• List all past surgical history",
        "",
        "Family History:",
        "• Mother: HTN",
        "• Father: CAD",
        "• Brother: DM II",
        "",
        "Social History:",
        "• Tobacco: Active Use (2 PPD × 20 years)",
        "• Alcohol: Negative",
        "• Substance Abuse: Negative",
        "",
        "Previous Diagnostic Studies:",
        "• ECHO/TTE Date",
        "• Carotid US Date",
        "• MPI/Stress Test Date",
        "• TEE/ECHO Date",
        "• PET Scan Date",
        "• Coronary Calcium Score Date",
        "• ABI/BLEA Date",
        "• Venous US/Venous US with Reflux Study Date",
        "• LHC Date, RHC Date",
        "• Peripheral Angiogram Date",
        "• CABG with Vessels Bypassed/Surgeon if available",
        "",
        "Review of Systems:",
        "• Constitutional: Fever, Chills, Sweats, Weakness",
        "• Eyes: N/A",
        "• ENMT: N/A",
        "• Respiratory: SOB, Cough, Sputum Production",
        "• Cardiovascular: Chest Pain (with location, palpitations, bradycardia, tachycardia, peripheral edema, syncope)",
        "• Gastrointestinal: Nausea, Vomiting, Heartburn, Abdominal Pain",
        "• Genitourinary: N/A",
        "• Lymph/Heme: N/A",
        "• Endocrine: N/A",
        "• Integumentary: Skin lesion – document peripheral wounds",
        "• Neurologic: Alert and Oriented × 4",
        "• Psychiatric: Anxiety, Depression",
        "• Other ROS: Always list negative findings in this section",
        "",
        "Medications:",
        "• List current and home medications",
        "",
        "Physical Examination Guidelines:",
        "• Select only pertinent positives and negatives",
        "• Do not document I&Os in this section",
        "",
        "Physical Examination Template:",
        "• General: Alert and Oriented/AMS [type in OTHER] and Distress Status",
        "• Eyes: EOMI and Normal Conjunctiva (Do not choose PERRLA or Vision Unchanged if you do not check them)",
        "• HENT: Normocephalic and Moist Oral Mucosa",
        "• Neck: Supple, Non-Tender and No JVD/ +JVD",
        "• Respiratory: Lung Sounds: Labored/Non-labored, Respirations: BS Equal, OTHER (e.g., O2 Support if on O2)",
        "• Cardiovascular: Rate: Normal, Bradycardia, Tachycardia, Rhythm: Regular or Irregular, Edema: Yes/No, Murmur: Type in OTHER (e.g., 1/6 SM, 2/6 SM, 3/6 SM)",
        "• Gastrointestinal: Soft, Non-Tender, Distended or Not, Bowel Sounds",
        "• Vital Signs: [Preset/entered separately]",
        "• Genitourinary and Lymphatics: N/A",
        "• Musculoskeletal: Normal ROM",
        "• Integumentary: Warm, Dry, Intact",
        "• For post-cath groins or CABG scars/CT/pacer sites: L CW Pacer Site: Soft/Flat, Non-Tender, No Sign of Bleed/Infection, No ecchymosis, Dermabond noted to incision",
        "• R Groin Site: Soft/Flat, Non-Tender, No Sign of Bleed/Infection, Distal Pedal Pulses Bilaterally +2, + per Doppler",
        "• R Radial Pulse: +2, capillary refill < 3 seconds, distal hand warm, no sign of bleed/infection",
        "• Midline incision: clean, dry, intact, open to air, no sign of bleed/infection noted",
        "• Neurologic: Alert, Oriented, No Focal Deficits",
        "• Psychiatric: Cooperative, Appropriate Mood and Affect, Normal Judgment",
        "",
        "Review / Management:",
        "• Deselected Results: (Lab Results not relevant for note)",
        "• Laboratory Results: Insert today's labs and pertinent results",
        "• CXR or Radiology Studies: Insert most recent diagnostics",
        "• Cardiology Results: Include hospitalization diagnostics such as LHC, ECHO, Peripheral, Carotid, etc.",
        "• Diagnostic Findings: Note specific findings (e.g., CABG with vessels bypassed)",
        "• Cardiac Monitor: Insert Date/Time, Rate and Rhythm – update daily",
        "• EKG: Enter most recent copy into OTHER tab and insert once prior to midnight daily",
        "• Condition: Stable, Fair, Guarded, Serious, Critical",
        "",
        "Impression and Plan:",
        "• Impression: [Click to Free Text]",
        "• Impression List / Diagnoses: List diagnoses (do not number or paste past findings)",
        "• Plan: List pertinent information including condition changes, ordered diagnostics, etc."
      ],
      "pearls": [
        "Use standardized templates for consistent documentation across providers",
        "Include pertinent positives and negatives in review of systems",
        "Document all previous cardiac studies with dates and key findings",
        "Update cardiac monitor and EKG findings daily",
        "Clearly justify admission reasons and clinical decision making",
        "Include social history details relevant to cardiac risk factors",
        "Document medication reconciliation thoroughly",
        "Use structured format for physical examination findings",
        "Include procedural site assessments for post-intervention patients",
        "Document condition status and clinical trajectory clearly",
        "Reference previous diagnostic studies chronologically",
        "Include family history of cardiac conditions systematically",
        "Document symptom progression and response to therapy",
        "Use standardized language for cardiac findings and assessments",
        "Include pertinent negative findings to support clinical reasoning"
      ]
    },
    {
      "id": "hfpef",
      "name": "Heart Failure with Preserved EF (HFpEF)",
      "description": "A clinical syndrome characterized by signs and symptoms of heart failure with preserved left ventricular ejection fraction.",
      "features": [
        "Exertional dyspnea",
        "Exercise intolerance",
        "Fatigue",
        "Edema"
      ],
      "workup": [
        "ECG",
        "BNP or NT‑proBNP (often elevated but lower than HFrEF for similar symptoms)",
        "Transthoracic echocardiogram (diastolic function, LA size, LV mass, RV/pulmonary pressures)",
        "CBC, CMP, Mg, TSH, fasting glucose/A1c, lipids",
        "CXR (congestion), consider sleep apnea screening"
      ],
      "management": [
        "Aggressive treatment of comorbidities: hypertension, obesity, diabetes, CKD, AF, OSA",
        "Diuretics for volume control (avoid over‑diuresis)",
        "Exercise training / cardiac rehab improves functional capacity",
        "ACEi/ARB/ARNI or CCB per BP and tolerance",
        "MRA (spironolactone) may reduce HF hospitalizations in selected patients",
        "SGLT2 inhibitor (empagliflozin/dapagliflozin) reduces HF hospitalizations",
        "Atrial fibrillation management (rate/rhythm control) and anticoagulation per CHA₂DS₂‑VASc",
        "Manage underlying left‑sided filling pressures; PAH‑specific drugs not beneficial unless Group 1 PAH"
      ],
      "pearls": [
        "Avoid routine nitrates for HFpEF symptom relief (no benefit)",
        "Use caution with aggressive preload reduction; patients are preload sensitive",
        "Optimize comorbidity control; periodic reassessment of diastolic parameters",
        "Titrate diuretics to weight and symptoms; monitor renal function and electrolytes",
        "Lifestyle and exercise prescription; weight loss for obesity",
        "Primary cardiology follow‑up within 2–4 weeks; earlier if recent decompensation"
      ],
      "pdfs": [
        {
          "title": "Congestive Heart Failure Clinical Notes",
          "path": "/src/assets/pdfs/cardiology/heart-failure/congestive-heart-failure-notes.pdf",
          "description": "Comprehensive guide to CHF pathophysiology, diagnosis, and management (6.6 MB)"
        },
        {
          "title": "Cardiomyopathy Clinical Notes",
          "path": "/src/assets/pdfs/cardiology/heart-failure/cardiomyopathy-notes.pdf",
          "description": "Comprehensive guide to cardiomyopathy types, diagnosis, and management (4.7 MB)"
        }
      ]
    },
    {
      "id": "hfref",
      "name": "Heart Failure with Reduced EF (HFrEF)",
      "description": "A clinical syndrome characterized by signs and symptoms of heart failure with reduced left ventricular ejection fraction.",
      "features": [
        "Dyspnea on exertion",
        "Orthopnea",
        "Paroxysmal nocturnal dyspnea",
        "Fatigue",
        "Weight gain",
        "Abdominal distension"
      ],
      "workup": [
        "ECG",
        "BNP or NT‑proBNP",
        "Transthoracic echocardiogram (EF, structure, valves, RV)",
        "CBC, CMP (BUN/Cr, LFTs), Mg, TSH",
        "Iron studies (if anemia or suspected deficiency)",
        "CXR (pulmonary edema, cardiomegaly)"
      ],
      "management": [
        "ARNI (sacubitril/valsartan preferred) OR ACEi/ARB if ARNI not feasible",
        "Evidence β‑blocker (carvedilol, metoprolol succinate, bisoprolol)",
        "MRA (spironolactone or eplerenone)",
        "SGLT2 inhibitor (dapagliflozin or empagliflozin)",
        "Loop diuretic (e.g., furosemide, bumetanide) titrated to euvolemia; consider thiazide add‑on for diuretic resistance",
        "Ivabradine (sinus rhythm, HR ≥70 bpm on max β‑blocker, EF ≤35%)",
        "Hydralazine/Isosorbide dinitrate (African ancestry or ACEi/ARB intolerance)",
        "Vericiguat (selected high‑risk patients with recent decompensation)",
        "Digoxin (rate control in AF or symptoms despite GDMT; narrow TI)",
        "ICD: EF ≤35% despite ≥3 months GDMT and good functional status",
        "CRT: LBBB with QRS ≥150 ms, EF ≤35%, persistent symptoms on GDMT",
        "Consider advanced therapies (LVAD, transplant) for refractory Stage D"
      ],
      "pearls": [
        "Target doses should be individualized to BP, renal function, and potassium.",
        "Consider iron repletion in iron deficiency (IV preferred in symptomatic HF).",
        "Up‑titrate GDMT every 2–4 weeks toward target doses as tolerated",
        "Reassess BMP/K+ within 1–2 weeks after initiating or uptitrating RAAS/MRA",
        "Repeat TTE 3–6 months after GDMT optimization",
        "Low‑sodium diet, fluid guidance, daily weights; action plan for rapid weight gain",
        "Early post‑discharge follow‑up within 7 days; consider HF disease management program",
        "Ensure 4‑pillar GDMT started or planned (ARNI/ACE/ARB, β‑blocker, MRA, SGLT2i)",
        "Loop diuretic with clear dose/goal and PRN plan",
        "Vaccinations and guideline lipid/BP therapy as indicated",
        "Close follow-up for HF management"
      ],
      "pdfs": [
        {
          "title": "Congestive Heart Failure Clinical Notes",
          "path": "/src/assets/pdfs/cardiology/heart-failure/congestive-heart-failure-notes.pdf",
          "description": "Comprehensive guide to CHF pathophysiology, diagnosis, and management (6.6 MB)"
        },
        {
          "title": "Cardiomyopathy Clinical Notes",
          "path": "/src/assets/pdfs/cardiology/heart-failure/cardiomyopathy-notes.pdf",
          "description": "Comprehensive guide to cardiomyopathy types, diagnosis, and management (4.7 MB)"
        }
      ]
    },
    {
      "id": "htn",
      "name": "Hypertension (HTN)",
      "description": "A chronic condition characterized by persistently elevated blood pressure (systolic >130 mmHg or diastolic >80 mmHg) that increases cardiovascular risk and can lead to end-organ damage.",
      "features": [
        "Usually asymptomatic at diagnosis",
        "Headache (uncommon, usually with severe HTN)",
        "Dizziness, blurred vision",
        "Epistaxis (nosebleeds)",
        "White coat hypertension: elevated in office but normal at home",
        "Masked hypertension: normal in office but elevated at home",
        "Secondary HTN clues: severe/resistant HTN, age <30, abdominal bruit, hypokalemia",
        "End-organ damage: LVH, retinopathy, CKD, CAD, stroke, PAD"
      ],
      "workup": [
        "Confirm diagnosis: elevated readings on ≥2 separate occasions [WHY: Single elevated reading insufficient - white coat hypertension affects 15-30%, multiple readings ensure true hypertension]",
        "Out-of-office BP measurement: ambulatory BP monitoring (ABPM) or home BP [WHY: Detects white coat HTN and masked HTN, 24-hour ABPM is gold standard for diagnosis]",
        "Staging: Stage 1 (130-139/80-89), Stage 2 (≥140/≥90) [WHY: Determines treatment urgency - Stage 2 requires immediate dual therapy, Stage 1 may start with lifestyle]",
        "Evaluate for secondary causes if: age <30, resistant HTN, abrupt onset, hypokalemia [WHY: 5-10% of HTN is secondary and potentially curable - early recognition saves lifelong treatment]",
        "Secondary HTN workup: renal artery duplex, plasma renin/aldosterone ratio, 24-hour urine metanephrines [WHY: Identifies specific causes - renal artery stenosis, primary aldosteronism, pheochromocytoma requiring targeted treatment]",
        "Assess end-organ damage: EKG (LVH), echocardiogram, UA (proteinuria), creatinine/eGFR, lipid panel [WHY: End-organ damage indicates need for aggressive treatment, affects cardiovascular risk stratification]",
        "Cardiovascular risk assessment: ASCVD risk calculator [WHY: Guides intensity of treatment - higher risk patients benefit from lower BP targets and statin therapy]",
        "Special populations: diabetics/CKD same target as general (<130/80), age >60 [WHY: Different populations have different risk-benefit profiles for BP targets based on clinical trial evidence]"
      ],
      "management": [
        "Lifestyle modifications: DASH diet, weight loss, exercise, sodium restriction (<2.3g/day), alcohol moderation",
        "Smoking cessation, stress reduction, adequate sleep",
        "Pharmacologic therapy: Start with monotherapy, titrate every 2-4 weeks",
        "First-line agents: Thiazide diuretics (chlorthalidone), ACEi/ARB, long-acting CCB (amlodipine)",
        "Comorbidity-based selection: Diabetes/CKD (ACEi/ARB), CAD/CHF (beta-blocker/ACEi/ARB), BPH (alpha-blocker)",
        "Stage 2 HTN: Start with 2 agents (usually including diuretic)",
        "Resistant HTN: ≥3 agents including diuretic, consider mineralocorticoid receptor antagonist",
        "BP goals: <130/80 mmHg for most, <130/80 for diabetics/CKD, <150/90 for age >60",
        "Monitor electrolytes, renal function, side effects",
        "Annual follow-up for stable patients, more frequent for uncontrolled"
      ],
      "pearls": [
        "HTN affects ~45% of US adults, leading cause of CVD mortality",
        "Essential HTN (>95%): idiopathic; Secondary HTN (~5%): renovascular, endocrine, drugs",
        "White coat HTN: 20-30% of diagnosed HTN, lower CV risk than sustained HTN",
        "Resistant HTN: uncontrolled on ≥3 agents including diuretic",
        "Secondary causes: renal artery stenosis (abdominal bruit), hyperaldosteronism (hypokalemia), pheochromocytoma (episodic)",
        "Medication adherence critical - most 'resistant' HTN is non-adherent",
        "Avoid NSAIDs in HTN patients (fluid retention, reduced diuretic efficacy)",
        "Regular BP monitoring at home improves control",
        "Age >60: permissive HTN (>150/90) unless diabetic/CKD",
        "Pregnancy: methyldopa, labetalol, nifedipine; avoid ACEi/ARB"
      ]
    },
    {
      "id": "htn_emergency",
      "name": "Hypertensive Emergency",
      "description": "Severely elevated blood pressure (usually >180/120) with acute end-organ damage requiring immediate but controlled BP reduction in a monitored setting.",
      "features": [
        "Severely elevated BP with acute end-organ damage",
        "Hypertensive encephalopathy: headache, confusion, seizures, coma",
        "Acute aortic dissection: severe chest/back pain, pulse deficits",
        "Acute coronary syndrome: chest pain, dyspnea, diaphoresis",
        "Acute kidney injury: oliguria, elevated creatinine",
        "Pulmonary edema: dyspnea, orthopnea, pink frothy sputum",
        "Malignant hypertension: papilledema, retinal hemorrhages/exudates",
        "Eclampsia: seizures, proteinuria in pregnancy",
        "Patient appears ill, may be in acute distress"
      ],
      "workup": [
        "Immediate assessment: ABCs, vital signs, neurologic exam [WHY: Hypertensive emergency is life-threatening - assess airway, breathing, circulation and neurologic function to guide immediate interventions]",
        "EKG: rule out ischemia, LV strain, arrhythmias [WHY: Severe hypertension can cause demand ischemia or acute MI, LV strain patterns indicate chronic damage]",
        "Chest X-ray: pulmonary edema, widened mediastinum [WHY: Identifies heart failure from severe HTN, widened mediastinum suggests aortic dissection requiring different treatment]",
        "Labs: CBC, BMP, troponin, UA, lactate [WHY: Assesses end-organ damage - kidney function (creatinine), cardiac damage (troponin), tissue perfusion (lactate)]",
        "CT/MRI brain if neurologic symptoms [WHY: Rules out stroke vs hypertensive encephalopathy - stroke contraindicates rapid BP lowering]",
        "CT angiogram if aortic dissection suspected [WHY: Aortic dissection requires immediate surgery and different BP targets than other hypertensive emergencies]",
        "Echocardiogram if cardiac involvement [WHY: Assesses for acute heart failure, wall motion abnormalities from ischemia, aortic regurgitation from dissection]",
        "Fundoscopic exam for papilledema [WHY: Optic disc swelling confirms severe end-organ damage, helps differentiate emergency from urgency]",
        "Pregnancy test in women of childbearing age [WHY: Eclampsia/preeclampsia requires different management - magnesium sulfate, delivery planning]"
      ],
      "management": [
        "Immediate but controlled BP reduction in ICU setting",
        "First 2 hours: reduce by ~20% of target",
        "First 24 hours: reduce by ~35% of target",
        "Avoid >30% reduction in first few hours",
        "Choice of agent based on clinical scenario:",
        "Aortic dissection: IV beta-blocker (labetalol/esmolol) + nitroprusside, target SBP <120",
        "ACS: nitroglycerin + beta-blocker, avoid nitroprusside",
        "Encephalopathy: labetalol or nicardipine",
        "Pulmonary edema: nitroglycerin + loop diuretic",
        "Eclampsia: magnesium sulfate + hydralazine or labetalol",
        "Continuous BP monitoring, frequent neurologic checks",
        "Transition to oral agents when stable",
        "Address underlying causes and long-term management"
      ],
      "pearls": [
        "Emergency = end-organ damage present, Urgency = no end-organ damage",
        "Too rapid BP reduction can cause ischemia/worsening",
        "Aortic dissection: reduce SBP <120 within 20 minutes",
        "Stroke: keep SBP <185/110 if thrombolysis/cath planned",
        "No single first-line agent - choice depends on presentation",
        "ICU admission required for all emergencies",
        "Continuous IV infusion preferred for precise control",
        "Transition to oral agents when patient stable",
        "Long-term follow-up essential to prevent recurrence",
        "Identify and treat underlying causes (medication non-adherence, secondary HTN)"
      ]
    },
    {
      "id": "htn_urgency",
      "name": "Hypertensive Urgency / Emergency",
      "description": "Severely elevated blood pressure with or without acute end-organ damage.",
      "features": [
        "Headache",
        "Visual changes",
        "Chest pain",
        "Dyspnea",
        "Neurologic deficits",
        "Oliguria"
      ],
      "workup": [
        "Focused exam for end-organ damage (neuro, cardio-pulm)",
        "BMP, UA",
        "ECG ± troponin",
        "CXR if pulmonary edema; Head CT if neuro deficits; Fundoscopy if concern for retinal hemorrhages"
      ],
      "management": [
        "Differentiate **Urgency** (no end-organ damage) vs **Emergency** (with damage)",
        "Urgency: oral agents, gradual reduction over 24–48h, close follow-up",
        "Emergency: ICU, IV meds; lower MAP ~10–20% in first hour, then additional 5–15% over next 23h (avoid rapid over-correction)",
        "Nicardipine, clevidipine, labetalol, esmolol, nitroprusside (monitor cyanide/thiocyanate), nitroglycerin (esp. ACS/pulmonary edema), hydralazine (selected settings, e.g., pregnancy)",
        "Aortic dissection: reduce HR/BP rapidly with β-blocker + vasodilator (SBP <120, HR <60)",
        "Ischemic stroke: follow thrombolysis/EVT BP thresholds",
        "Preeclampsia/eclampsia: labetalol, hydralazine, or nifedipine; magnesium for seizure prophylaxis"
      ],
      "pearls": [
        "Avoid precipitous BP drops that risk cerebral/coronary ischemia",
        "ACEi/ARB/ARNI contraindicated in pregnancy",
        "Close outpatient follow-up within days after urgency; ensure long-term regimen optimization"
      ]
    },
    {
      "id": "hcm",
      "name": "Hypertrophic Cardiomyopathy (HCM)",
      "description": "A genetic condition causing abnormal thickening of the heart muscle, potentially leading to obstruction and arrhythmias.",
      "features": [
        "Dyspnea",
        "Chest pain",
        "Palpitations",
        "Syncope, esp. exertional"
      ],
      "workup": [
        "Echo (asymmetric septal hypertrophy, systolic anterior motion of mitral valve, dynamic LVOT gradient)",
        "ECG (LVH, repolarization abnormalities)",
        "Holter/event monitor (arrhythmias)",
        "Cardiac MRI for morphology/fibrosis",
        "Genetic testing in selected patients"
      ],
      "management": [
        "β-blockers (first-line) or non-DHP CCBs (verapamil, diltiazem)",
        "Avoid dehydration, excessive exertion, vasodilators, diuretics (↓ preload)",
        "ICD if prior cardiac arrest, sustained VT, or high-risk features",
        "Septal reduction (surgical myectomy or alcohol ablation) if refractory symptoms with gradient",
        "Transplant if end-stage HF"
      ],
      "pearls": [
        "Annual echo if symptomatic or every 1–2y if stable",
        "Family screening with echo/ECG",
        "Cardiology/HCM specialist follow-up"
      ]
    },
    {
      "id": "hcm",
      "name": "Hypertrophic Cardiomyopathy (HCM)",
      "description": "Genetic cardiac muscle disease characterized by myocardial hypertrophy in the absence of hemodynamic stress, often with asymmetric septal hypertrophy.",
      "features": [
        "Dyspnea on exertion (most common)",
        "Chest pain (atypical, may mimic angina)",
        "Palpitations and arrhythmias",
        "Syncope or near-syncope (especially with exertion)",
        "Fatigue and exercise intolerance",
        "Family history of sudden cardiac death",
        "May be asymptomatic in early stages"
      ],
      "clinical_triggers": {
        "symptoms_any": [
          "Dyspnea",
          "Chest pain",
          "Palpitations",
          "Syncope, esp. exertional"
        ],
        "signs_any": [
          "Harsh systolic murmur at LSB/apex, ↑ with Valsalva, ↓ with squatting",
          "S4 gallop",
          "Family history of sudden death"
        ]
      },
      "workup": [
        "Echocardiogram: Diagnostic test of choice [WHY: Shows asymmetric septal hypertrophy, SAM, dynamic LVOT obstruction]",
        "Key findings: septal thickness ≥15mm, systolic anterior motion of mitral valve",
        "ECG: Often abnormal [WHY: Shows LVH with repolarization abnormalities, helps identify high-risk features]",
        "Findings: LVH, deep Q waves, T-wave inversions, atrial enlargement",
        "Holter/event monitoring: Assess for arrhythmias [WHY: VT/VF detection guides ICD therapy decisions]",
        "Exercise stress testing: Evaluate symptoms and blood pressure response [WHY: Abnormal BP response indicates higher risk]",
        "Cardiac MRI: Advanced imaging [WHY: Better tissue characterization, identifies fibrosis, guides risk stratification]",
        "Cardiac catheterization: If LVOT gradient unclear [WHY: Provocative maneuvers can unmask dynamic obstruction]",
        "Genetic testing: Recommended for probands [WHY: Identifies specific mutations, guides family screening]",
        "Family screening: First-degree relatives [WHY: 50% inheritance rate, early detection prevents sudden death]"
      ],
      "management": [
        "β-blockers: First-line therapy [WHY: Reduces LVOT gradient, improves diastolic filling, controls arrhythmias]",
        "Preferred: metoprolol, propranolol, atenolol",
        "Non-dihydropyridine CCBs: Alternative therapy [WHY: Verapamil/diltiazem improve diastolic function]",
        "Disopyramide: For refractory LVOT obstruction [WHY: Negative inotrope reduces gradient]",
        "ICD therapy: High-risk patients [WHY: Prevents sudden cardiac death in high-risk features]",
        "Indications: prior cardiac arrest, sustained VT, family history of SCD, massive LVH (≥30mm)",
        "Septal reduction therapy: Refractory symptoms with significant gradient",
        "Options: surgical myectomy (gold standard) or alcohol septal ablation",
        "Activity restrictions: Avoid competitive sports, high-intensity exercise",
        "Genetic counseling: For patients and families"
      ],
      "contraindications": {
        "avoid_medications": [
          "Vasodilators (nitrates, ACEi/ARB) - worsen LVOT obstruction",
          "Diuretics (unless volume overloaded) - reduce preload, worsen gradient",
          "Digoxin - increases contractility, worsens obstruction",
          "Dihydropyridine CCBs (nifedipine, amlodipine) - vasodilation worsens gradient"
        ],
        "activity_restrictions": [
          "Competitive sports participation prohibited",
          "Avoid dehydration and extreme heat",
          "Limit high-intensity exercise"
        ]
      },
      "pearls": [
        "Most common genetic cardiovascular disease (1:500 prevalence)",
        "Autosomal dominant inheritance - 50% of offspring affected",
        "Leading cause of sudden cardiac death in young athletes",
        "Murmur increases with Valsalva, decreases with squatting (opposite of most murmurs)",
        "Symptoms often develop in adolescence or young adulthood",
        "Pregnancy generally well-tolerated with proper management",
        "Annual cardiology follow-up recommended for all patients",
        "Family screening should continue every 3-5 years until age 50+",
        "Consider advanced heart failure therapies if develops systolic dysfunction"
      ],
      "pdfs": [
        {
          "title": "Cardiomyopathy Clinical Notes",
          "path": "/src/assets/pdfs/cardiology/heart-failure/cardiomyopathy-notes.pdf",
          "description": "Comprehensive guide to cardiomyopathy types, diagnosis, and management (4.7 MB)"
        }
      ]
    },
    {
      "id": "hypovolemic_shock",
      "name": "Hypovolemic Shock",
      "description": "Shock due to inadequate circulating blood volume from blood loss or plasma loss.",
      "features": [
        "Pathophysiology: ↓Blood volume → ↓Venous return → ↓Preload → ↓SV → ↓CO → ↓BP",
        "Cold, pale, mottled extremities (compensatory ↑SVR)",
        "Reflex tachycardia, hypotension with narrow pulse pressure",
        "Altered mental status, oliguria, delayed capillary refill",
        "Blood plasma loss: GI (vomiting, diarrhea), skin (burns, diaphoresis), renal (diuretics)",
        "Blood loss: Trauma, GI bleeding, AAA rupture, postpartum hemorrhage, surgical bleeding"
      ],
      "workup": [
        "CBC: Hemoglobin trend (drop from baseline), platelet count",
        "BUN/Cr ratio: >20:1 suggests prerenal AKI from volume depletion",
        "Lactate: >2 mmol/L indicates tissue hypoperfusion",
        "Swan-Ganz findings: ↓CVP (<5 mmHg), ↓PCWP (<12 mmHg), ↓CI, ↑SVR, ↓SvO2",
        "Source identification: CT imaging, endoscopy, surgical exploration as indicated"
      ],
      "management": [
        "IV access: 2 large bore IVs, type and crossmatch",
        "Crystalloid resuscitation: Normal saline or LR, initial 20-30 mL/kg bolus",
        "Blood products: PRBCs if Hgb <7 g/dL or symptomatic, FFP/platelets if coagulopathy",
        "Source control: Endoscopy (GI bleed), surgery (trauma), interventional procedures",
        "Monitoring: Continuous vitals, urine output >0.5 mL/kg/hr, serial Hgb and lactate"
      ],
      "pearls": [
        "Avoid excessive fluid in concomitant heart failure",
        "Blood transfusion goal Hgb >7 g/dL (>10 g/dL if active CAD)",
        "Massive transfusion protocol: 1:1:1 ratio PRBC:FFP:Platelets",
        "Early source control prevents ongoing losses",
        "Documentation: 'Hemoglobin dropped from 12.1 to 8.3 g/dL, concerning for ongoing blood loss'"
      ]
    },
    {
      "id": "infective_endocarditis",
      "name": "Infective Endocarditis",
      "description": "Infection of the endocardial surface of the heart that extends to the heart valves. Risk factors include valvular heart disease, congenital heart disease, prosthetic heart valves, immunosuppression, age over 60, injection drug use.",
      "features": [
        "New or changing murmur",
        "Janeway lesions (painless plaques on palms and soles)",
        "Osler nodes (painful nodules on fingers and toes)",
        "Roth spots (pale retinal lesions with hemorrhage)",
        "Fever, chills, night sweats",
        "Fatigue, dyspnea",
        "Stroke symptoms from emboli",
        "Splenomegaly, petechiae",
        "Conjunctival hemorrhages"
      ],
      "workup": [
        "Blood cultures: Three sets, separated by one hour, before starting antibiotics [WHY: 95% sensitive when done properly, timing separation increases yield, must obtain before antibiotics destroy organisms]",
        "Echocardiogram: TTE initial, TEE if negative or complications suspected [WHY: TTE only 60% sensitive for vegetations, TEE 95% sensitive - detects abscesses, perforations, extent of valve damage]",
        "CBC, ESR/CRP, renal function [WHY: CBC shows leukocytosis/anemia, ESR/CRP track treatment response, renal function guides antibiotic dosing]",
        "CXR if pulmonary symptoms (right-sided IE) [WHY: Right-sided endocarditis causes septic pulmonary emboli - multiple bilateral infiltrates on CXR]",
        "Duke Criteria for diagnosis [WHY: Standardized criteria combining clinical, microbiologic, and echocardiographic findings for accurate diagnosis]",
        "Definitive: 2 major, or 1 major + 3 minor, or 5 minor criteria",
        "Major: Positive blood culture, echocardiographic evidence, new regurgitant murmur",
        "Minor: Predisposition, fever, vascular phenomena, immunologic phenomena, positive cultures not meeting major",
        "Colonoscopy if Streptococcus bovis or Clostridium septicum [WHY: Strong association with colon cancer - up to 25% of patients have malignancy requiring screening]"
      ],
      "management": [
        "Start empiric therapy: Ceftriaxone or vancomycin + gentamicin until cultures return",
        "Tailor antibiotics to culture results for 4-6 weeks IV therapy",
        "Common organisms: Streptococcus viridans (native valves), Staphylococcus aureus (IV drug users), Coagulase-negative staph (prosthetic valves)",
        "HACEK organisms: Haemophilus, Actinobacillus, Cardiobacterium, Eikenella, Kingella (require 5 days culture)",
        "Surgery if heart failure, uncontrolled infection, large vegetations with emboli, abscess",
        "Anticoagulation generally avoided in acute IE with CNS emboli (hemorrhage risk)",
        "Monitor renal function, drug levels (aminoglycosides, vancomycin)"
      ],
      "pearls": [
        "Prophylaxis with amoxicillin indicated for:",
        "  - History of endocarditis",
        "  - Prosthetic valves",
        "  - Unrepaired cyanotic congenital heart disease",
        "  - Cardiac transplant with valvulopathy",
        "Procedures requiring prophylaxis: Dental (gingival), respiratory invasive, skin infection treatment",
        "Repeat blood cultures to document clearance",
        "Monitor for complications: Heart failure, emboli, abscess, conduction abnormalities",
        "Adherence to prolonged IV antibiotic therapy (often via PICC)",
        "Report fevers, embolic symptoms, new murmurs",
        "Dental hygiene critical to reduce recurrence risk",
        "Infectious disease and cardiology co-management",
        "Consider outpatient parenteral antibiotic therapy (OPAT) when stable"
      ]
    },
    {
      "id": "lbbb",
      "name": "Left Bundle Branch Block (LBBB)",
      "description": "Electrical activity in the left bundle branch is slowed, causing delayed activation of the left ventricle.",
      "features": [
        "Often indicates underlying cardiac pathology",
        "Associated with hypertension, coronary artery disease, cardiomyopathy",
        "May be rate-related (tachycardia-induced)",
        "Can cause dyssynchronous ventricular contraction",
        "May progress to complete heart block",
        "Associated with left ventricular dysfunction"
      ],
      "workup": [
        "12-lead ECG: Wide QRS (>0.12 sec), notched R wave in I/aVL/V5/V6, absent Q wave in I/V5/V6",
        "ST/T wave displacement opposite to QRS deflection",
        "Echocardiogram to assess LV function and wall motion",
        "Coronary angiography if ischemia suspected",
        "Cardiac MRI for infiltrative or inflammatory disease",
        "Electrophysiology study if conduction disease suspected",
        "Holter monitor for intermittent LBBB"
      ],
      "management": [
        "Treat underlying cardiac disease (HTN, CAD, cardiomyopathy)",
        "New LBBB in ACS setting: Treat as STEMI equivalent",
        "Pacemaker consideration for symptomatic bradycardia or heart failure",
        "CRT consideration if LBBB + reduced EF + heart failure symptoms",
        "Beta-blockers for rate control if tachycardia-induced",
        "Address reversible causes (electrolytes, ischemia)",
        "Regular monitoring for progression to advanced AV block"
      ],
      "pearls": [
        "New LBBB = STEMI equivalent - activate cath lab immediately",
        "LBBB can mask anterolateral STEMI - look for concordant ST changes",
        "LBBB + RBBB = complete heart block",
        "LBBB with wide QRS may indicate ventricular tachycardia",
        "Associated with dilated cardiomyopathy and aortic stenosis",
        "May improve with treatment of underlying disease",
        "CRT improves outcomes in LBBB with reduced EF",
        "Serial ECGs to monitor for resolution or progression"
      ]
    },
    {
      "id": "long_qt",
      "name": "Long QT Syndrome (LQTS)",
      "description": "A disorder of the heart's electrical system that can cause fast, chaotic heartbeats.",
      "features": [
        "Syncope",
        "Seizure-like episodes",
        "Palpitations",
        "Sudden cardiac arrest"
      ],
      "workup": [
        "12-lead ECG (QT interval measurement)",
        "Holter/event monitor if intermittent",
        "Family history, genetic testing if congenital LQTS suspected",
        "Labs: electrolytes, thyroid, drug screen"
      ],
      "management": [
        "Avoid QT-prolonging drugs (macrolides, fluoroquinolones, antiarrhythmics, antipsychotics, methadone, etc.)",
        "Correct electrolyte abnormalities (K+, Mg2+, Ca2+)",
        "β-blockers (nadolol, propranolol) for congenital LQTS",
        "ICD if history of cardiac arrest, recurrent syncope/VT despite β-blocker",
        "Left cardiac sympathetic denervation in refractory cases",
        "IV magnesium sulfate for Torsades de Pointes",
        "Overdrive pacing or isoproterenol if bradycardic"
      ],
      "pearls": [
        "Adherence to β-blocker therapy",
        "Avoid QT-prolonging drugs (provide list)",
        "Family screening for congenital forms",
        "Electrophysiology/genetics follow-up"
      ]
    },
    {
      "id": "mitraclip_postop",
      "name": "MitraClip (Post-Operative Care by NP)",
      "description": "Post-operative care following MitraClip transcatheter edge-to-edge repair procedure for mitral regurgitation.",
      "features": [
        "Post-procedure monitoring for complications",
        "Assessment of groin access sites",
        "Evaluation of cardiac status and symptoms",
        "Monitoring for pericardial effusion or tamponade"
      ],
      "workup": [
        "ECHO: Post-op day 1; discharge after ECHO is complete and no pericardial effusion present",
        "Monitoring: Groin sites, peripheral pulses",
        "Vital signs assessment",
        "Pain assessment at access sites",
        "Cardiac rhythm monitoring"
      ],
      "management": [
        "Anticoagulation: Managed by operating physician",
        "Pain management at groin sites",
        "Mobilization as tolerated",
        "Diet advancement as appropriate",
        "Patient education on activity restrictions",
        "Follow-up appointment scheduling",
        "Discharge planning coordination"
      ],
      "pearls": [
        "Monitor for signs of infection at access sites",
        "Assess for post-procedure complications (tamponade, stroke, vascular injury)",
        "Ensure adequate pain control before discharge",
        "Patient education on medication adherence and follow-up",
        "Coordinate with cardiology team for ongoing care",
        "Document baseline ECHO findings for comparison"
      ]
    },
    {
      "id": "mr",
      "name": "Mitral Regurgitation",
      "description": "Backflow of blood from the left ventricle into the left atrium due to mitral valve insufficiency.",
      "features": [
        "Etiologies: Mitral valve prolapse, coronary artery disease",
        "Symptoms: Dyspnea, fatigue, syncope (often asymptomatic early)",
        "Murmur: Holosystolic murmur at the apex, radiating to axilla",
        "Dyspnea",
        "Fatigue",
        "Palpitations",
        "Acute MR: pulmonary edema, shock"
      ],
      "workup": [
        "Transthoracic echo (jet severity, LA/LV size, function, mechanism)",
        "TEE if needed for mechanism/surgical planning",
        "ECG (AF, LA enlargement)",
        "CXR (cardiomegaly, pulmonary congestion)"
      ],
      "management": [
        "Treatment: Asymptomatic → observation; Symptomatic → vasodilators; Surgery if severe or progressive",
        "Treat HTN, AF, and heart failure symptoms",
        "Afterload reduction (ACEi/ARB, vasodilators) in acute or symptomatic MR if not immediately surgical",
        "Symptomatic severe MR or LVEF ≤60% or LVESD ≥40 mm → mitral surgery (repair preferred over replacement)",
        "Acute severe MR (papillary rupture, chordal rupture, endocarditis): urgent surgery",
        "MitraClip (TEER) for selected patients not surgical candidates"
      ],
      "pearls": [
        "Use cautiously in preload-dependent patients with acute MR and hypotension",
        "Echo surveillance: mild q3–5y, moderate q1–2y, severe q6–12mo",
        "Report new or worsening dyspnea, edema, or palpitations",
        "Maintain dental hygiene to reduce endocarditis risk",
        "Cardiology/valve clinic follow-up per severity",
        "Acute MR from papillary muscle rupture is surgical emergency",
        "Chronic MR may be asymptomatic for years"
      ]
    },
    {
      "id": "ms",
      "name": "Mitral Stenosis",
      "description": "Narrowing of the mitral valve opening, restricting blood flow from the left atrium to the left ventricle.",
      "features": [
        "Etiology: Rheumatic disease",
        "Symptoms: Dyspnea, orthopnea, atrial fibrillation, hemoptysis; symptoms exacerbated in pregnancy",
        "Murmur: Low-pitched diastolic rumble at apex",
        "Exertional dyspnea",
        "Orthopnea",
        "Fatigue",
        "Hemoptysis (rare)"
      ],
      "workup": [
        "Transthoracic echo (valve area, mean gradient, LA size, pulmonary pressures)",
        "ECG (LA enlargement, AF common)",
        "CXR (LA enlargement, pulmonary congestion)"
      ],
      "management": [
        "Treatment: Balloon valvotomy or surgery; diuretics and beta blockers for symptom control",
        "Diuretics for pulmonary congestion",
        "Rate control (β-blocker, diltiazem, digoxin) if AF",
        "Anticoagulation if AF, prior embolism, or LA thrombus",
        "Percutaneous balloon mitral valvotomy if suitable anatomy",
        "Surgical repair/replacement if not suitable or concurrent valve disease"
      ],
      "pearls": [
        "Careful management; balloon valvotomy considered if severe symptoms",
        "Echo q3–5y (mild), q1–2y (moderate), annually (severe)",
        "Report new-onset dyspnea, palpitations, or hemoptysis",
        "Endocarditis prophylaxis only in select prosthetic/high-risk cases",
        "Cardiology follow-up per severity and rhythm status",
        "Pregnancy worsens symptoms due to increased cardiac output",
        "Monitor for progression to atrial fibrillation"
      ]
    },
    {
      "id": "mvp",
      "name": "Mitral Valve Prolapse",
      "description": "Prolapse of one or both mitral valve leaflets into the left atrium during systole.",
      "features": [
        "Epidemiology: Most common in women",
        "Symptoms: Usually asymptomatic; may have chest pain, palpitations, anxiety",
        "Murmur: Mid-systolic click with a possible late systolic murmur (severity dependent)"
      ],
      "workup": [
        "Transthoracic echo (leaflet prolapse, regurgitation severity, chordal rupture)",
        "ECG (nonspecific changes, arrhythmias)",
        "Holter monitoring if palpitations"
      ],
      "management": [
        "Treatment: Beta blockers",
        "Asymptomatic: reassurance and follow-up",
        "Symptomatic: beta-blockers for palpitations, chest pain",
        "Anticoagulation if AF or prior embolic event",
        "Surgical repair if severe MR develops"
      ],
      "pearls": [
        "Most patients asymptomatic and require no treatment",
        "Regular echo surveillance for progression to MR",
        "Beta-blockers effective for symptoms",
        "Endocarditis prophylaxis not routinely recommended",
        "Family screening may be considered"
      ]
    },
    {
      "id": "myocarditis",
      "name": "Myocarditis",
      "description": "Inflammation of the heart muscle, often due to viral infection.",
      "features": ["Chest pain", "Dyspnea", "Palpitations", "Syncope"],
      "workup": [
        "Troponin",
        "ECG",
        "Echo",
        "Cardiac MRI",
        "Endomyocardial biopsy (select)"
      ],
      "management": [
        "Supportive HF therapy",
        "Avoid NSAIDs/ETOH",
        "Immunosuppression if giant cell/autoimmune",
        "Mechanical support, transplant if refractory"
      ],
      "pearls": ["No exercise until cleared", "Cardiology"]
    },
    {
      "id": "obstructive_shock",
      "name": "Obstructive Shock",
      "description": "Shock due to mechanical obstruction of cardiac filling or outflow.",
      "features": [
        "Reduced preload: ↑RV filling pressures → ↓Venous return → ↓Preload → ↓SV → ↓CO",
        "High afterload: ↑Pulmonary artery pressure → ↓SV → ↓CO → ↓BP",
        "Cold, pale, mottled extremities (↓CO → compensatory ↑SVR)",
        "JVD (elevated central venous pressure), reflex tachycardia",
        "Cardiac tamponade: Beck's triad (JVD, muffled heart sounds, hypotension), pulsus paradoxus >10 mmHg",
        "Tension pneumothorax: Absent breath sounds, hyperresonance, tracheal deviation",
        "Massive PE: Dyspnea, chest pain, tachycardia, hypoxemia, S1Q3T3 pattern"
      ],
      "workup": [
        "Swan-Ganz findings: ↑CVP (>15 mmHg), ↓PCWP (except tamponade), ↓CI, ↑SVR, ↓SvO2",
        "Tamponade: Echo (pericardial effusion, RV collapse), ECG (low voltage, electrical alternans)",
        "Tension PTX: CXR (complete lung collapse, mediastinal shift), clinical diagnosis",
        "Massive PE: CT-PE, V/Q scan, elevated D-dimer, Echo (RV strain)"
      ],
      "management": [
        "Tamponade: Emergency pericardiocentesis (even small drainage improves hemodynamics)",
        "Tension PTX: Immediate needle thoracostomy → chest tube placement",
        "Massive PE: Anticoagulation + thrombolytics (tPA 100 mg over 2 hours) or embolectomy",
        "General: Treat underlying cause immediately, maintain preload, avoid excessive PPV",
        "Supportive: Oxygen, vasopressors after source control"
      ],
      "pearls": [
        "Pericardiocentesis contraindications: Aortic dissection with hemopericardium",
        "Thrombolytic contraindications: Active bleeding, recent surgery, intracranial pathology",
        "Avoid fluid overload in RV strain from massive PE",
        "Emergency procedures save lives - don't delay for imaging if unstable",
        "Documentation: 'Beck's triad present, concerning for cardiac tamponade'"
      ]
    },
    {
      "id": "orthostatic_hypotension",
      "name": "Orthostatic Hypotension",
      "description": "Occurs due to autonomic dysfunction and is an inadequate physiological response to postural changes. More common in patients >65 years.",
      "features": [
        "Dizziness upon standing",
        "Palpitations",
        "Syncope",
        "Lightheadedness",
        "Weakness",
        "Visual disturbances"
      ],
      "workup": [
        "Measure BP lying down → then after standing for 2 minutes",
        "Diagnosis: systolic drop ≥20 mmHg or diastolic drop ≥10 mmHg",
        "Tilt table testing if suspicion remains despite normal vitals",
        "Orthostatic vital signs: Document HR and BP lying, sitting, standing",
        "Measure at 2-minute intervals",
        "Assess for underlying causes (medications, hypovolemia, anemia, etc.)"
      ],
      "management": [
        "Address underlying cause",
        "Have patients rise slowly from supine to standing (especially in mornings)",
        "Increase fluid and sodium intake",
        "If persistent: fludrocortisone (mineralocorticoid) is first-line therapy",
        "Compression stockings",
        "Medication review and adjustment",
        "Physical therapy for strengthening exercises"
      ],
      "pearls": [
        "Common in elderly patients",
        "Review medications for hypotensive agents",
        "Encourage adequate hydration",
        "Teach patients to change positions slowly",
        "Monitor for falls and injury prevention",
        "Consider referral to cardiology if autonomic dysfunction suspected"
      ]
    },
    {
      "id": "psvt",
      "name": "Paroxysmal Supraventricular Tachycardia (PSVT)",
      "description": "Intermittent, abrupt-onset supraventricular tachycardias originating above the ventricles, most commonly AV nodal reentry or AV reentry.",
      "features": [
        "Sudden onset and termination of palpitations",
        "Regular heart rate 150-250 bpm",
        "Shortness of breath, chest pain, dizziness",
        "Altered mental status or hypotension if prolonged",
        "May be triggered by caffeine, stress, or exercise",
        "Associated with Wolff-Parkinson-White syndrome",
        "History of similar episodes in past"
      ],
      "workup": [
        "12-lead ECG during episode: Narrow complex tachycardia, regular rhythm",
        "Holter monitor or event recorder for documentation",
        "Echocardiogram to rule out structural heart disease",
        "Electrolyte panel and thyroid function",
        "Consider EPS for recurrent or refractory cases",
        "Exercise stress testing to reproduce symptoms",
        "Carotid massage or Valsalva under monitoring (diagnostic)"
      ],
      "management": [
        "Acute termination: Vagal maneuvers (Valsalva, carotid massage)",
        "Adenosine 6mg IV push (first-line pharmacologic)",
        "If adenosine ineffective: Diltiazem or metoprolol IV",
        "Unstable patients: Immediate synchronized cardioversion",
        "Chronic prevention: Beta-blockers, calcium channel blockers, digoxin",
        "Antiarrhythmic drugs: Flecainide, propafenone for refractory cases",
        "Catheter ablation (curative) for recurrent symptomatic PSVT",
        "Patient education about vagal maneuvers and trigger avoidance"
      ],
      "pearls": [
        "Adenosine is diagnostic and therapeutic for SVT vs VT",
        "Vagal maneuvers successful in 20-30% of cases",
        "PSVT rarely degenerates to VF (unlike VT)",
        "WPW patients may develop rapid AF through accessory pathway",
        "Avoid verapamil in WPW (may accelerate ventricular rate)",
        "Ablation success rate >95% for AVNRT and AVRT",
        "Recurrent PSVT may indicate underlying SVT substrate",
        "Holter monitoring helpful for asymptomatic episodes"
      ]
    },
    {
      "id": "pda",
      "name": "Patent Ductus Arteriosus (PDA)",
      "description": "Persistence of the ductus arteriosus beyond the first 24 hours of life, causing abnormal blood flow between the aorta and pulmonary artery.",
      "features": [
        "Small PDA: often asymptomatic",
        "Moderate PDA: wide pulse pressure, bounding pulses, continuous machine-like murmur",
        "Large PDA: heart failure, poor growth, frequent respiratory infections",
        "Preterm infants: predisposed due to pulmonary compromise",
        "Physical exam: continuous murmur throughout systole and diastole",
        "Best heard at left infraclavicular area",
        "Differential cyanosis (pink upper body, blue lower body) in severe cases"
      ],
      "workup": [
        "Echocardiogram: ductal anatomy, shunt magnitude, pulmonary pressures",
        "Chest X-ray: cardiomegaly, increased pulmonary vascularity",
        "ECG: LVH, LAE if large shunt",
        "CTA: most accurate test for ductal anatomy",
        "Labs: BNP elevated in heart failure"
      ],
      "management": [
        "Infancy: Keep PDA open with prostaglandins if dependent on PDA (TOF, TGA, hypoplastic left heart, pulmonary atresia)",
        "Premature infants: indomethacin/ibuprofen to close PDA",
        "Term infants: percutaneous catheter closure or surgical ligation",
        "Device closure: preferred method if suitable anatomy",
        "Medical management: diuretics, ACEi for heart failure symptoms",
        "Pulmonary hypertension management if present",
        "Endocarditis prophylaxis: 6 months post-closure"
      ],
      "pearls": [
        "Ductus arteriosus normally closes within first 24 hours due to rising oxygen levels",
        "Prostaglandins maintain patency, indomethacin/ibuprofen promote closure",
        "Qp:Qs ratio >1.5 indicates significant shunt requiring closure",
        "Serial echocardiograms to monitor ductal size and pulmonary pressures",
        "Risk of pulmonary hypertension if untreated",
        "Device closure has lower complication rate than surgery",
        "Report dyspnea, poor feeding, recurrent infections, or cyanosis",
        "Lifelong cardiology follow-up",
        "Pregnancy generally well-tolerated but requires monitoring"
      ]
    },
    {
      "id": "pericardial_effusion",
      "name": "Pericardial Effusion / Tamponade",
      "description": "Excess pericardial fluid exerts pressure on the heart → restricted filling and hemodynamic compromise.",
      "features": [
        "Beck's Triad: hypotension, muffled heart sounds, distended neck veins",
        "Pulsus paradoxus (decrease in SBP >10 mmHg during inspiration)",
        "Lungs clear, narrowed pulse pressure",
        "Dyspnea",
        "Chest pressure",
        "Fatigue",
        "Tachycardia"
      ],
      "workup": [
        "EKG: electrical alternans (QRS complexes alternate in amplitude)",
        "Chest X-ray: enlarged cardiac silhouette, clear lung fields",
        "Echocardiogram: pericardial effusion, diastolic collapse of right-sided chambers",
        "Definitive diagnosis and treatment: pericardiocentesis"
      ],
      "management": [
        "Immediate pericardiocentesis or surgical drainage",
        "Volume resuscitation if hypotensive",
        "Treat underlying cause (malignancy, infection, autoimmune, trauma)",
        "Monitor for recurrence",
        "Serial echocardiograms post-drainage"
      ],
      "pearls": [
        "Serial echo after drainage",
        "Monitor for recurrence depending on etiology",
        "Report syncope, hypotension, or worsening dyspnea immediately",
        "Medication adherence (if autoimmune/inflammatory)",
        "Cardiology follow-up; oncology/rheum/nephrology if secondary cause",
        "Urgent intervention required - do not delay pericardiocentesis",
        "Consider tamponade in any patient with pericardial effusion + hypotension"
      ]
    },
    {
      "id": "perioperative_medication_management",
      "name": "Perioperative Medication Management",
      "description": "Guidelines for managing cardiovascular medications around the time of surgery (Adapted from CIS Guidelines – Preoperative Risk Assessment, updated 9/27/18).",
      "features": [
        "Key point: Although adapted for outpatient settings, this policy can be applied to acute care with physician collaboration",
        "Individualized decision-making based on thrombosis vs bleeding risk",
        "Collaboration between surgeon, cardiologist, and anesthesiologist essential",
        "Consider procedure-specific bleeding risk and patient comorbidities"
      ],
      "workup": [
        "Assess CHA₂DS₂-VASc score for atrial fibrillation patients on anticoagulation",
        "Evaluate coronary stent type and timing (DES vs BMS)",
        "Determine procedure bleeding risk (low, intermediate, high)",
        "Review recent cardiac events or interventions",
        "Assess renal function for DOAC dosing",
        "Check for drug interactions affecting perioperative management"
      ],
      "management": [
        "Anticoagulants:",
        "Xarelto/Eliquis/Savaysa/Pradaxa: Hold 24–48 hrs pre-op; restart 24–48 hrs post-op (decision made by surgeon & cardiologist)",
        "Coumadin for A-fib: If CHA₂DS₂-VASc ≤4 and no history of ischemic CVA/TIA → hold 4–5 days, depending on INR; recheck INR within 24 hrs pre-op",
        "Coumadin for A-fib: If CHA₂DS₂-VASc ≥5 or history of ischemic CVA/TIA → consider bridging (decision individualized)",
        "Coumadin for Mechanical Valve: Bridge unless procedure is very low risk; decision individualized",
        "Coumadin for DVT/PE: Bridge unless recent CVA/AVR",
        "Aspirin: Hold 5–7 days pre-op unless contraindicated",
        "Antiplatelets (Clopidogrel, Effient, Brilinta) - Coronary stents:",
        "DES <12 months: Delay elective surgery if possible. If non-cardiac surgery required, evaluate thrombosis risk (especially with multivessel CAD, CHF, DM)",
        "BMS <1 month: Delay surgery if possible",
        "DES >12 months: May hold antiplatelet for 7 days with surgeon approval",
        "Antiplatelets - Peripheral stents: 3 months: Hold antiplatelet for 7 days pre-op and resume post-op per surgeon approval",
        "Antiplatelets - Peripheral stents: <3 months: Defer surgery if possible"
      ],
      "pearls": [
        "Balance thrombosis risk vs bleeding risk for each patient",
        "Document perioperative medication plan in medical record",
        "Clear communication between all providers involved",
        "Consider heparin bridging for high thrombosis risk patients",
        "Resume full anticoagulation regimen as soon as hemostasis achieved",
        "Monitor for post-operative bleeding complications",
        "Involve cardiology for complex anticoagulation management",
        "Patient education regarding medication changes and resumption timing"
      ]
    },
    {
      "id": "pad",
      "name": "Peripheral Arterial Disease (PAD)",
      "description": "Peripheral arterial disease (PAD) commonly coexists with coronary artery disease. Narrowing of the peripheral arteries, reducing blood flow to the limbs.",
      "features": [
        "Classic presentation: angina of the legs (pain with exertion, relieved with rest)",
        "Claudication (exertional leg pain relieved by rest)",
        "Rest pain (advanced)",
        "Non-healing wounds",
        "Blue toe",
        "May also show: pallor, ulcers, diminished pulses, hair loss"
      ],
      "workup": [
        "Ankle-Brachial Index (ABI): Ratio of BP in ankle to BP in arm",
        "Positive test if ABI <0.9 (ankle BP lower than arm BP)",
        "Ankle-brachial index (ABI): PAD if ≤0.90",
        "Toe-brachial index for diabetics or non-compressible vessels",
        "Exercise ABI if symptoms and normal resting ABI",
        "Duplex ultrasound for anatomic assessment; CTA/MRA when planning revascularization"
      ],
      "management": [
        "Medical: Aspirin, BP/lipid/glucose control (as in CAD)",
        "First step in treatment: Supervised 12-week exercise regimen",
        "Medication: Cilostazol (only drug shown to provide medical benefit in PAD)",
        "Smoking cessation",
        "High-intensity statin",
        "Antiplatelet therapy (aspirin or clopidogrel)",
        "Optimize BP, diabetes; consider SGLT2i/GLP-1 RA for CV benefit in DM",
        "Cilostazol improves walking distance (avoid in HFrEF)",
        "Endovascular or surgical revascularization for lifestyle-limiting claudication refractory to therapy or critical limb-threatening ischemia"
      ],
      "pearls": [
        "Foot care education, wound surveillance in high-risk patients",
        "ABI surveillance after revascularization per protocol",
        "Daily foot inspection, protective footwear",
        "Adherence to exercise therapy and medications",
        "Vascular/cardiology follow-up; wound care as needed"
      ]
    },
    {
      "id": "pheochromocytoma",
      "name": "Pheochromocytoma / Paraganglioma",
      "description": "Tumors that arise from the adrenal gland tissue and cause excess production of catecholamines.",
      "features": [
        "Paroxysmal HTN",
        "Headaches",
        "Palpitations",
        "Sweating",
        "Panic attacks"
      ],
      "workup": [
        "Plasma free metanephrines (preferred screening)",
        "24h urine catecholamines/metanephrines",
        "CT/MRI abdomen-pelvis for localization",
        "MIBG or PET for metastatic/extra-adrenal disease"
      ],
      "management": [
        "α-blockade (phenoxybenzamine or doxazosin) 7–14d before surgery",
        "Then add β-blocker after α-blockade if tachycardia",
        "Surgical resection (laparoscopic adrenalectomy if adrenal)"
      ],
      "pearls": [
        "Never start β-blocker before α-blockade — risk hypertensive crisis",
        "Medication adherence pre-surgery",
        "Report headaches, palpitations, diaphoresis",
        "Endocrinology follow-up, genetic counseling for familial cases"
      ]
    },
    {
      "id": "pac",
      "name": "Premature Atrial Contraction (PAC)",
      "description": "Ectopic beats originating from the atria outside the SA node, causing early atrial depolarization.",
      "features": [
        "Often asymptomatic or felt as skipped beats",
        "Palpitations, chest discomfort, anxiety",
        "Associated with caffeine, stress, alcohol, smoking",
        "May be frequent or occur in patterns",
        "Can trigger atrial fibrillation",
        "More common with age and comorbidities",
        "May indicate atrial irritability"
      ],
      "workup": [
        "12-lead ECG: Early P wave with different morphology, may be non-conducted",
        "Holter monitor to quantify PAC burden",
        "Echocardiogram to rule out structural heart disease",
        "Thyroid function and electrolyte panel",
        "Consider sleep study if nocturnal PACs",
        "Exercise testing to assess autonomic tone",
        "Event monitor for symptom correlation"
      ],
      "management": [
        "Asymptomatic PACs: No treatment required",
        "Symptomatic PACs: Beta-blockers or calcium channel blockers",
        "Frequent PACs: Address underlying causes (caffeine, stress)",
        "Antiarrhythmic therapy for refractory cases",
        "Lifestyle modifications: Reduce stimulants, improve sleep",
        "Rate/rhythm control if PACs trigger AF",
        "Regular monitoring for progression to sustained arrhythmias",
        "Patient education about benign nature"
      ],
      "pearls": [
        "PACs are common and usually benign",
        "Frequent PACs (>100/hour) may predict AF development",
        "PACs can be suppressed by vagal maneuvers",
        "Associated with hypertension, sleep apnea, obesity",
        "May be first sign of digitalis toxicity",
        "Exercise can increase PAC frequency in some patients",
        "No specific PVC burden threshold for treatment",
        "Monitor for atrial fibrillation development"
      ]
    },
    {
      "id": "pvc",
      "name": "Premature Ventricular Contraction (PVC)",
      "description": "Ectopic beats originating from the ventricles, interrupting the normal cardiac rhythm.",
      "features": [
        "Often asymptomatic, felt as skipped beats",
        "Palpitations, chest discomfort, anxiety",
        "May be frequent (>1000/day) or infrequent",
        "Associated with caffeine, stress, electrolyte abnormalities",
        "May indicate underlying heart disease",
        "Bigeminy, trigeminy, or couplets pattern",
        "R-on-T phenomenon (increased VF risk)"
      ],
      "workup": [
        "12-lead ECG: Wide QRS without preceding P wave, compensatory pause",
        "Holter monitor to quantify PVC burden",
        "Echocardiogram to assess cardiac structure and function",
        "Exercise stress testing to evaluate ischemia",
        "Electrolyte panel and thyroid function",
        "Consider cardiac MRI if cardiomyopathy suspected",
        "24-hour ambulatory monitoring for correlation with symptoms"
      ],
      "management": [
        "Benign PVCs (<1000/day, asymptomatic): No treatment",
        "Symptomatic PVCs: Beta-blockers (metoprolol, propranolol)",
        "Frequent PVCs (>10% of beats): Antiarrhythmics (amiodarone, mexiletine)",
        "Address underlying causes (electrolytes, ischemia, drugs)",
        "Catheter ablation for refractory symptomatic PVCs",
        "Lifestyle modifications: Reduce caffeine, stress, alcohol",
        "ICD consideration if PVCs trigger VT/VF",
        "Regular follow-up to monitor PVC burden and symptoms"
      ],
      "pearls": [
        "PVC burden >10% associated with PVC-induced cardiomyopathy",
        "R-on-T PVCs increase sudden death risk",
        "PVCs common in healthy individuals (1-4% of beats)",
        "Exercise suppresses PVCs in healthy hearts",
        "Frequent PVCs may indicate occult coronary disease",
        "Ablation success rate >80% for symptomatic PVCs",
        "Beta-blockers first-line for symptomatic PVCs",
        "Monitor for QT prolongation with antiarrhythmic therapy"
      ]
    },
    {
      "id": "primary_aldosteronism",
      "name": "Primary Aldosteronism",
      "description": "A condition of excessive aldosterone secretion, leading to hypertension and electrolyte imbalances.",
      "features": [
        "Often asymptomatic",
        "Headache",
        "Fatigue",
        "Muscle weakness/cramps",
        "Polyuria/polydipsia"
      ],
      "workup": [
        "Plasma aldosterone concentration (PAC) / plasma renin activity (PRA) ratio (screening)",
        "Confirmatory tests: saline suppression, oral salt loading, fludrocortisone suppression",
        "Adrenal CT to localize adenoma vs hyperplasia",
        "Adrenal vein sampling if surgery considered"
      ],
      "management": [
        "Laparoscopic adrenalectomy for unilateral adenoma",
        "Mineralocorticoid receptor antagonist (spironolactone, eplerenone) for bilateral hyperplasia"
      ],
      "pearls": [
        "Medication adherence if MRA prescribed",
        "Report gynecomastia, hyperkalemia (spironolactone side effects)",
        "Endocrinology and cardiology follow-up"
      ]
    },
    {
      "id": "pe",
      "name": "Pulmonary Embolism (PE)",
      "description": "Blockage of the pulmonary arteries by blood clots, fat, or air bubbles.",
      "features": [
        "Dyspnea",
        "Pleuritic chest pain",
        "Cough",
        "Hemoptysis",
        "Syncope if massive PE"
      ],
      "workup": [
        "Wells or Geneva score [WHY: Risk stratifies patients - low risk can be ruled out with D-dimer alone, avoiding unnecessary radiation and contrast exposure]",
        "D-dimer (rule out in low/intermediate risk) [WHY: High sensitivity but low specificity - negative D-dimer in low-risk patients safely rules out PE]",
        "CT pulmonary angiography (diagnostic) [WHY: Gold standard test - directly visualizes clots in pulmonary arteries, assesses RV strain and clot burden]",
        "V/Q scan if CTA contraindicated [WHY: Alternative when contrast allergy, pregnancy, or renal dysfunction - uses ventilation/perfusion mismatch to detect PE]",
        "Echo for RV strain if massive/submassive [WHY: RV dysfunction predicts poor outcomes and guides decision for thrombolysis vs embolectomy]"
      ],
      "management": [
        "DOAC preferred if not contraindicated",
        "LMWH in pregnancy or cancer",
        "Systemic thrombolysis (alteplase) if shock/hemodynamic collapse and no contraindications",
        "Catheter-directed thrombolysis or surgical embolectomy if thrombolysis contraindicated/failed",
        "Anticoagulation mainstay in submassive PE; Thrombolysis considered if worsening RV dysfunction or clinical decline"
      ],
      "pearls": [
        "Recent major surgery, hemorrhagic stroke, active bleeding: contraindications to thrombolysis",
        "Medication adherence to anticoagulation",
        "Report bleeding, recurrent chest pain/dyspnea",
        "Encourage ambulation as tolerated",
        "Hematology/pulmonology follow-up; duration based on provoked vs unprovoked"
      ],
      "clinical_triggers": {
        "symptoms_any": [
          "Dyspnea",
          "Pleuritic chest pain",
          "Cough",
          "Hemoptysis",
          "Syncope if massive PE"
        ],
        "signs_any": [
          "Tachypnea, tachycardia",
          "Hypoxemia",
          "Signs of DVT",
          "Hypotension/shock if massive"
        ]
      },
      "contraindications": {
        "thrombolysis": [
          "Recent major surgery, hemorrhagic stroke, active bleeding"
        ]
      },
      "discharge": {
        "instructions": [
          "Medication adherence to anticoagulation",
          "Report bleeding, recurrent chest pain/dyspnea",
          "Encourage ambulation as tolerated"
        ],
        "follow_up": [
          "Hematology/pulmonology follow-up; duration based on provoked vs unprovoked"
        ]
      }
    },
    {
      "id": "pulmonary_htn",
      "name": "Pulmonary Hypertension",
      "description": "Increased blood pressure in the pulmonary arteries, leading to dyspnea and other symptoms.",
      "features": ["Dyspnea", "Fatigue", "Syncope"],
      "workup": [
        "Echo (RVSP)",
        "RHC (gold standard)",
        "CT chest, V/Q scan for cause"
      ],
      "management": [
        "Diuretics, O2, anticoagulation in CTEPH",
        "Endothelin receptor antagonists, PDE5 inhibitors, prostacyclin analogs"
      ],
      "pearls": ["Report syncope, edema", "Pulmonary HTN specialist"]
    },
    {
      "id": "pr",
      "name": "Pulmonic Regurgitation",
      "description": "Backflow of blood from the pulmonary artery into the right ventricle due to pulmonary valve insufficiency.",
      "features": [
        "Etiology: Pulmonary hypertension",
        "Murmur: Decrescendo diastolic murmur",
        "Often asymptomatic"
      ],
      "workup": [
        "Transthoracic echo (regurgitation severity, RV size/function)",
        "ECG (RVH if severe)",
        "CXR (pulmonary artery enlargement)"
      ],
      "management": [
        "Treat underlying pulmonary hypertension",
        "Surgical replacement if severe symptomatic PR",
        "Regular monitoring for RV dysfunction"
      ],
      "pearls": [
        "Often well-tolerated for years",
        "Monitor RV function closely",
        "Surgical intervention rare",
        "Associated with pulmonary hypertension",
        "Echo surveillance based on severity"
      ]
    },
    {
      "id": "ps",
      "name": "Pulmonic Stenosis",
      "description": "Narrowing of the pulmonary valve opening, restricting blood flow from the right ventricle to the pulmonary artery.",
      "features": [
        "Rare, usually congenital",
        "Murmur: systolic, best heard at left upper sternal border",
        "May radiate to left shoulder",
        "Associated with congenital syndromes"
      ],
      "workup": [
        "Transthoracic echo (valve gradient, RV hypertrophy, pulmonary pressures)",
        "ECG (RVH)",
        "CXR (post-stenotic dilation of pulmonary artery)"
      ],
      "management": [
        "Balloon valvuloplasty for significant stenosis",
        "Surgical valvotomy if balloon unsuccessful",
        "Regular follow-up for progression",
        "Endocarditis prophylaxis"
      ],
      "pearls": [
        "Often asymptomatic until severe",
        "Balloon valvuloplasty first-line treatment",
        "Monitor for RV dysfunction",
        "Associated with Noonan syndrome, Tetralogy of Fallot",
        "Regular echo surveillance"
      ]
    },
    {
      "id": "pulm_valve",
      "name": "Pulmonic Valve Disease",
      "description": "Diseases affecting the pulmonic valve, including stenosis and regurgitation.",
      "features": [
        "Often asymptomatic if mild",
        "Dyspnea on exertion",
        "Fatigue",
        "Right-sided heart failure symptoms (advanced)"
      ],
      "workup": [
        "Transthoracic echo (valve morphology, gradients, regurgitant jet, RV size/function)",
        "ECG (RVH, RA enlargement)",
        "CXR (pulmonary artery dilation, RV enlargement)"
      ],
      "management": [
        "Balloon valvuloplasty for symptomatic severe PS (or asymptomatic severe with RV dysfunction)",
        "Surgery if not suitable for balloon or with other lesions",
        "Treat underlying pulmonary HTN",
        "Valve replacement if severe PR with RV dilation/dysfunction and symptoms"
      ],
      "pearls": [
        "Serial echo for moderate/severe lesions, RV size/function monitoring",
        "Report exertional dyspnea, edema, syncope",
        "Maintain dental hygiene (endocarditis risk if prosthetic valve)",
        "Cardiology/congenital specialist follow-up depending on etiology"
      ]
    },
    {
      "id": "renal_artery_stenosis",
      "name": "Renal Artery Stenosis (RAS)",
      "description": "Narrowing of one or both renal arteries, reducing blood flow to the kidneys.",
      "features": [
        "Often asymptomatic",
        "May present with resistant HTN",
        "Flash pulmonary edema",
        "Worsening renal function on ACEi/ARB"
      ],
      "workup": [
        "Renal duplex Doppler ultrasound (screening)",
        "CTA or MRA (noninvasive anatomic imaging)",
        "Renal angiography (gold standard, usually for intervention)"
      ],
      "management": [
        "ACEi/ARB (cautiously, monitor creatinine)",
        "Statins, antiplatelets, BP control, smoking cessation",
        "Angioplasty ± stent in select patients (recurrent flash pulmonary edema, refractory HTN, progressive renal failure)"
      ],
      "pearls": [
        "Monitor BP and kidney function regularly",
        "Medication adherence (ACEi/ARB, statin, antiplatelet)",
        "Nephrology/vascular follow-up"
      ]
    },
    {
      "id": "rcm",
      "name": "Restrictive Cardiomyopathy (RCM)",
      "description": "A condition in which the heart muscle becomes rigid and less elastic, impairing diastolic filling.",
      "features": ["Dyspnea", "Fatigue", "Edema", "Ascites"],
      "workup": [
        "Echo (normal LV size, biatrial enlargement, impaired diastolic filling, normal/small LV cavity)",
        "Cardiac MRI (fibrosis, infiltrative disease)",
        "ECG (low voltage, arrhythmias)",
        "BNP, iron studies, SPEP/UPEP (amyloidosis), genetic testing if indicated",
        "Endomyocardial biopsy in select cases"
      ],
      "management": [
        "Treat underlying cause (amyloidosis, hemochromatosis, sarcoidosis)",
        "Diuretics for volume management (cautious)",
        "Rate/rhythm control for AF, anticoagulation",
        "Advanced therapies (transplant) if refractory"
      ],
      "pearls": [
        "Monitor volume status, renal function",
        "Serial imaging for progression",
        "Adherence to therapy, report edema/ascites",
        "Genetic counseling for inherited forms",
        "Cardiology follow-up; specialty clinics if infiltrative disease"
      ]
    },
    {
      "id": "rcm",
      "name": "Restrictive Cardiomyopathy (RCM)",
      "description": "Cardiac muscle disease characterized by impaired ventricular filling with preserved systolic function, resulting in elevated filling pressures.",
      "features": [
        "Progressive dyspnea on exertion",
        "Fatigue and exercise intolerance",
        "Peripheral edema and ascites",
        "Right heart failure symptoms predominate",
        "Chest pain (less common)",
        "Syncope (advanced cases)",
        "May have systemic symptoms if infiltrative disease"
      ],
      "clinical_triggers": {
        "symptoms_any": ["Dyspnea", "Fatigue", "Edema", "Ascites"],
        "signs_any": [
          "JVD with prominent y descent",
          "Right > left HF signs",
          "S4 common unless AF"
        ]
      },
      "workup": [
        "Echocardiogram: Key diagnostic test [WHY: Shows normal LV size, biatrial enlargement, impaired diastolic filling, preserved EF]",
        "Findings: restrictive filling pattern, elevated E/e' ratio, enlarged atria",
        "Cardiac MRI: Superior tissue characterization [WHY: Identifies infiltrative diseases, fibrosis patterns, guides biopsy]",
        "Late gadolinium enhancement patterns help differentiate causes",
        "ECG: Often abnormal [WHY: Low voltage suggests infiltrative disease, conduction abnormalities common]",
        "Findings: low voltage, arrhythmias, conduction blocks",
        "Right heart catheterization: Confirms diagnosis [WHY: Shows equalization of diastolic pressures, square root sign]",
        "Laboratory studies: Screen for systemic diseases [WHY: Identifies treatable causes]",
        "BNP elevated, SPEP/UPEP (amyloidosis), iron studies (hemochromatosis)",
        "Endomyocardial biopsy: Often necessary [WHY: Provides tissue diagnosis for infiltrative diseases]",
        "Genetic testing: If familial disease suspected [WHY: Identifies inherited forms]"
      ],
      "management": [
        "Treat underlying cause when possible [WHY: May halt or reverse disease progression]",
        "Amyloidosis: tafamidis (TTR), chemotherapy (AL), supportive care",
        "Hemochromatosis: phlebotomy or chelation therapy",
        "Sarcoidosis: corticosteroids and immunosuppression",
        "Diuretics: Cautious use for volume management [WHY: Improves symptoms but patients preload-dependent]",
        "Rate and rhythm control: For atrial fibrillation [WHY: Maintain atrial contribution to filling]",
        "Anticoagulation: For atrial fibrillation or high risk [WHY: High thromboembolic risk due to enlarged atria]",
        "Heart transplantation: Advanced cases with poor prognosis [WHY: Definitive therapy for end-stage disease]",
        "Avoid aggressive diuresis: Patients are preload-sensitive",
        "Palliative care: For systemic diseases with poor prognosis"
      ],
      "pearls": [
        "Least common form of cardiomyopathy but highest mortality",
        "Must differentiate from constrictive pericarditis (surgical vs medical treatment)",
        "Cardiac amyloidosis: Look for carpal tunnel, macroglossia, periorbital purpura",
        "TTR amyloidosis: Often affects elderly males, may be misdiagnosed as HFpEF",
        "Hemochromatosis: Bronze diabetes, arthropathy, hepatomegaly",
        "Sarcoidosis: Pulmonary involvement, lymphadenopathy, skin lesions",
        "Endomyocardial fibrosis: Rare, associated with eosinophilia",
        "Prognosis depends on underlying etiology and response to treatment",
        "Genetic counseling indicated for familial forms"
      ],
      "pdfs": [
        {
          "title": "Cardiomyopathy Clinical Notes",
          "path": "/src/assets/pdfs/cardiology/heart-failure/cardiomyopathy-notes.pdf",
          "description": "Comprehensive guide to cardiomyopathy types, diagnosis, and management (4.7 MB)"
        }
      ]
    },
    {
      "id": "rheumatic_hd",
      "name": "Rheumatic Heart Disease",
      "description": "Heart damage resulting from rheumatic fever, affecting the heart valves.",
      "features": [
        "History of untreated strep throat",
        "Migratory arthritis",
        "Fever",
        "Carditis symptoms (dyspnea, palpitations)",
        "Sydenham chorea"
      ],
      "workup": [
        "Throat culture or rapid strep test (initial infection)",
        "ASO/anti-DNase B titers",
        "Echo (valve lesions, carditis)",
        "Jones Criteria for diagnosis (2 major or 1 major + 2 minor)"
      ],
      "management": [
        "Penicillin (or erythromycin if allergic) for GAS eradication",
        "NSAIDs for arthritis",
        "Corticosteroids if severe carditis",
        "Secondary prophylaxis with IM benzathine penicillin every 3–4 weeks (duration depends on severity, often 10+ years)",
        "Valve repair/replacement for severe chronic MR/MS"
      ],
      "pearls": [
        "Monitor for progression to valvular disease (esp. MS, MR)",
        "Long-term adherence to antibiotic prophylaxis",
        "Importance of strep throat treatment",
        "Strict adherence to prophylaxis regimen",
        "Report new dyspnea, palpitations, or edema",
        "Cardiology follow-up; infectious disease if recurrent strep"
      ]
    },
    {
      "id": "rbbb",
      "name": "Right Bundle Branch Block (RBBB)",
      "description": "Electrical activity in the right bundle branch (His-Purkinje fibers) is slowed, causing delayed activation of the right ventricle.",
      "features": [
        "Often asymptomatic",
        "May be associated with underlying heart disease",
        "Can be congenital or acquired",
        "May progress to complete heart block",
        "Associated with pulmonary hypertension, ASD, pulmonary embolism",
        "Exercise-induced RBBB may indicate ischemia"
      ],
      "workup": [
        "12-lead ECG: Wide QRS (>0.12 sec), RSR' pattern in V1-V3, S wave wider than R wave in I and V6",
        "Echocardiogram to evaluate cardiac structure and function",
        "Chest X-ray to assess for cardiomegaly or pulmonary disease",
        "Exercise stress testing if ischemia suspected",
        "Electrolyte panel and thyroid function",
        "Consider cardiac MRI if infiltrative disease suspected"
      ],
      "management": [
        "Asymptomatic patients: No treatment required, routine follow-up",
        "Symptomatic patients: Treat underlying cause",
        "Pacemaker consideration for symptomatic conduction disturbances",
        "Address reversible causes (electrolytes, medications, ischemia)",
        "Regular ECG monitoring for progression",
        "Exercise restrictions if symptomatic during exertion",
        "Patient education about symptoms requiring medical attention"
      ],
      "pearls": [
        "RBBB is common and often benign in young healthy individuals",
        "New RBBB in setting of chest pain requires ACS evaluation",
        "RBBB + LAFB = bifascicular block (pacemaker consideration)",
        "Exercise-induced RBBB may indicate right ventricular ischemia",
        "RBBB can mask inferior STEMI - look for ST changes in other leads",
        "Associated with pulmonary hypertension and right heart strain",
        "May be first sign of progressive conduction system disease",
        "Family history screening if congenital RBBB suspected"
      ]
    },
    {
      "id": "shock",
      "name": "Shock - Comprehensive Guide",
      "description": "Inadequate tissue perfusion and oxygen delivery resulting in cellular dysfunction. Four main types: hypovolemic, obstructive, distributive, and cardiogenic.",
      "features": [
        "General features: ↓BP → ↓MAP → organ malperfusion → organ failure",
        "Shock Index (SI) = HR/SBP: Normal <1.0, SI >1.0 suggests shock",
        "Lactate >2 mmol/L indicates tissue hypoperfusion",
        "Hypovolemic/Obstructive/Cardiogenic: Cold, pale, mottled extremities (↓CO → ↑SVR)",
        "Distributive: Warm, pink/red extremities (↓SVR → compensatory ↑CO)",
        "Reflex tachycardia (except AV blocks, β-blocker overdose, neurogenic shock)",
        "Organ-specific complications: Encephalopathy, NSTEMI, AKI, bowel ischemia, ischemic hepatitis"
      ],
      "workup": [
        "Shock Index calculation: HR/SBP [WHY: Simple bedside tool to identify shock - >1.0 suggests shock, can detect shock before BP drops below 90 mmHg]",
        "Lactate level: MOST IMPORTANT single test [WHY: Best marker of tissue hypoperfusion and cellular oxygen debt - >2 mmol/L significant, >4 mmol/L severe]",
        "Lactate trends guide resuscitation effectiveness - elevated lactate = anaerobic metabolism from poor perfusion",
        "Complete Blood Count (CBC) [WHY: Identifies shock type and complications]",
        "Hemoglobin: Assess for blood loss (hypovolemic shock)",
        "WBC with differential: Infection (sepsis/distributive shock)",
        "Platelets: Bleeding risk assessment, DIC screening",
        "Comprehensive Metabolic Panel (CMP) [WHY: Assesses organ function and metabolic consequences]",
        "Creatinine: Kidney function (prerenal AKI common in shock)",
        "Anion gap >12: Suggests metabolic acidosis",
        "Electrolytes: K+ abnormalities affect cardiac function",
        "Arterial Blood Gas (ABG) [WHY: Quantifies acid-base status and oxygenation]",
        "pH <7.35 with base excess <-5 = metabolic acidosis",
        "Confirms tissue hypoperfusion, guides ventilator management",
        "Troponin: Rule out cardiac causes [WHY: MI can cause cardiogenic shock OR be complication of shock - demand ischemia from hypotension common]",
        "Liver Function Tests (LFTs) [WHY: Detects 'shock liver' from prolonged hypoperfusion - AST/ALT >1000 suggests ischemic hepatitis]",
        "Swan-Ganz catheter: For undifferentiated shock [WHY: Differentiates shock types when etiology unclear - guides targeted therapy]",
        "Hemodynamic differentiation by Swan-Ganz values:",
        "Hypovolemic: ↓CVP, ↓PCWP, ↓CI, ↑SVR, ↓SvO2",
        "Cardiogenic: ↑CVP, ↑PCWP, ↓CI, ↑SVR, ↓SvO2",
        "Distributive: ↓CVP, ↓PCWP, ↑CI, ↓↓SVR, ↑SvO2",
        "Obstructive: ↑CVP, variable PCWP, ↓CI, ↑SVR, ↓SvO2"
      ],
      "management": [
        "Hypovolemic: IV fluids (crystalloids) for plasma loss, blood products for blood loss",
        "Obstructive: Treat cause - pericardiocentesis (tamponade), chest tube (tension PTX), tPA (PE)",
        "Distributive: Treat cause + vasopressors if MAP <65 mmHg",
        "Cardiogenic: Inotropes (dobutamine, milrinone) + mechanical support (IABP, ECMO)",
        "General supportive care: Maintain MAP ≥65 mmHg, address metabolic complications",
        "Serial lactate monitoring q2-4h during resuscitation",
        "Organ support: CRRT for AKI, ventilatory support, stress ulcer prophylaxis"
      ],
      "pearls": [
        "Distributive shock is the ONLY type with ↓↓SVR (others have compensatory ↑SVR)",
        "Neurogenic and cardiogenic shock are ONLY types with hypotension + bradycardia",
        "Swan-Ganz findings: Hypovolemic (↓CVP,↓PCWP,↓CI,↑SVR), Obstructive (↑CVP,↓PCWP,↓CI,↑SVR)",
        "Swan-Ganz findings: Cardiogenic (↑CVP,↑PCWP,↓CI,↑SVR), Distributive (↓CVP,↓PCWP,↑CI,↓SVR)",
        "Avoid IV fluids in cardiogenic shock (↑pulmonary edema)",
        "Early recognition key: Shock index and lactate before obvious hypotension",
        "Documentation: Include shock index, specific hemodynamic parameters, response to interventions"
      ]
    },
    {
      "id": "sss",
      "name": "Sick Sinus Syndrome (SSS)",
      "description": "SA node dysfunction characterized by inappropriate sinus bradycardia, sinus pauses, or bradycardia-tachycardia syndrome.",
      "features": [
        "Fatigue, dizziness, syncope, presyncope",
        "Alternating bradycardia and tachycardia (bradycardia-tachycardia syndrome)",
        "Inappropriate pauses (>3 seconds)",
        "May be asymptomatic until advanced",
        "Associated with age, hypertension, coronary disease",
        "May be drug-induced or post-cardiac surgery",
        "Progressive nature with worsening symptoms"
      ],
      "workup": [
        "12-lead ECG: Sinus bradycardia, sinus pauses, atrial fibrillation",
        "Holter monitor: Document pauses and arrhythmia patterns",
        "Exercise stress testing: Assess chronotropic incompetence",
        "Echocardiogram: Evaluate cardiac structure and function",
        "Electrophysiology study: Confirm SA node dysfunction",
        "Tilt table testing: For vasovagal symptoms",
        "Electrolyte and thyroid function",
        "Consider sleep study for nocturnal pauses"
      ],
      "management": [
        "Asymptomatic patients: No treatment, regular monitoring",
        "Symptomatic patients: Permanent pacemaker (first-line)",
        "Rate-responsive pacemaker preferred",
        "Address reversible causes (medications, electrolytes, ischemia)",
        "Antiarrhythmic therapy for tachycardia component",
        "Driving restrictions during evaluation",
        "Regular device interrogation and follow-up",
        "Patient education about device and symptoms"
      ],
      "pearls": [
        "Pacemaker indicated for symptomatic sinus bradycardia",
        "Tachycardia-bradycardia syndrome common in SSS",
        "SA node dysfunction often progressive",
        "May be first manifestation of atrial disease",
        "Associated with atrial fibrillation development",
        "Pacemaker prevents sudden death from prolonged pauses",
        "Rate-responsive pacing improves exercise tolerance",
        "Device infection and lead complications require vigilance"
      ]
    },
    {
      "id": "svt",
      "name": "Supraventricular Tachycardia (SVT)",
      "description": "A rapid heart rate originating above the ventricles, often due to reentrant circuits.",
      "features": ["Palpitations", "Dizziness", "Chest discomfort", "Dyspnea"],
      "workup": [
        "12-lead ECG during episode",
        "Telemetry strip",
        "Labs (K+, Mg2+, TSH if indicated)",
        "Echo if structural disease suspected"
      ],
      "management": [
        "Immediate synchronized cardioversion if unstable",
        "Vagal maneuvers",
        "Adenosine IV push (diagnostic and therapeutic)",
        "IV β-blocker or diltiazem if refractory",
        "Catheter ablation for recurrent symptomatic SVT",
        "β-blockers or nondihydropyridine CCBs as alternatives if not ablation candidate"
      ],
      "pearls": [
        "Avoid stimulants (caffeine, sympathomimetics) that trigger SVT",
        "Seek urgent care if episodes prolonged or associated with syncope",
        "EP referral for recurrent episodes",
        "Patient education on vagal maneuvers",
        "Cardiology/EP follow-up"
      ]
    },
    {
      "id": "surgical_risk_stratification",
      "name": "Surgical Risk Stratification",
      "description": "Assessment of perioperative cardiac risk for non-cardiac surgery using validated tools and clinical factors.",
      "features": [
        "Functional Status/Capacity assessment critical for risk stratification",
        "Poor (1 MET): Can take care of self only (eating, dressing, toileting)",
        "Moderate (4 METs): Can walk up a flight of stairs, walk uphill, or walk on level ground at 3–4 mph",
        "Moderate (4–6 METs) and Good (7–10 METs): Can do heavy housework (scrubbing floors, moving furniture, climbing multiple flights of stairs)",
        "Excellent (>10 METs): Can participate in strenuous sports (swimming, singles tennis, football, basketball, skiing)"
      ],
      "workup": [
        "Download MD Calc Application (Android or Apple)",
        "Assess Revised Cardiac Risk Index (RCRI) using application (document results in HPI)",
        "Evaluate patient's functional capacity and document in HPI",
        "Timing of holding blood thinners and antiplatelets (see perioperative medication management)",
        "Dual antiplatelet therapy: Need to know procedure, date, and type of stent (BMS vs DES)",
        "Full OAC (oral anticoagulation): Warfarin with INR/therapeutic reasoning, or DOACs (Eliquis, Xarelto, Pradaxa, Savaysa)",
        "If on Coumadin: identify reasoning (mechanical valve, DVT, atrial fibrillation, etc.)",
        "Revised Cardiac Risk Index (RCRI) assessment",
        "History of ischemic heart disease",
        "History of heart failure",
        "History of cerebrovascular disease (CVA)",
        "Insulin-dependent diabetes mellitus",
        "Pre-op serum creatinine ≥2.0 mg/dL",
        "Increasing age",
        "ASA class (American Society of Anesthesiologists)",
        "Preoperative functional status",
        "Other risk factors: Atrial fibrillation, obesity"
      ],
      "management": [
        "Risk Stratification Categories:",
        "Low Risk (0–1%): Patient considered low risk for cardiac events",
        "Elevated Risk (≥2%): Patient considered elevated risk for cardiac events",
        "Note: Applies to cardiac events only (not cerebrovascular events such as CVA)",
        "Risk Calculator Findings:",
        "No risk factors → 0.4% event rate",
        "One risk factor → 1% event rate",
        "Two risk factors → 2.4% event rate",
        "Three or more risk factors → 5.4% event rate",
        "Surgical risk stratification should also take into account comorbidities such as atrial fibrillation and diabetes",
        "Consulting surgeons should be provided with precautions geared toward pre- and post-operative care, as well as cardiovascular monitoring after the procedure",
        "Consider perioperative beta-blocker for high-risk patients",
        "Optimize medical therapy pre-operatively",
        "Consider coronary revascularization if indicated",
        "Multidisciplinary evaluation for high-risk patients",
        "Post-operative cardiac monitoring based on risk level"
      ],
      "pearls": [
        "Download and use MD Calc app for RCRI calculation",
        "Document RCRI results and functional capacity assessment in HPI",
        "Low Risk (0-1%): Generally proceed with surgery without additional cardiac testing",
        "Elevated Risk (≥2%): Consider cardiology consultation and additional evaluation",
        "Functional capacity >4 METs generally low risk for most surgeries",
        "RCRI ≥2 indicates need for perioperative cardiac evaluation",
        "Emergency surgery increases risk 2-5 fold",
        "Consider type of surgery (vascular > thoracic > abdominal > orthopedic)",
        "Individualize approach based on patient comorbidities",
        "Involve cardiology consultation for RCRI ≥2 or poor functional status",
        "Continue evidence-based cardiac medications perioperatively when possible",
        "Monitor for post-operative cardiac complications",
        "Provide surgeons with cardiovascular precautions and monitoring plans"
      ]
    },
    {
      "id": "syncope",
      "name": "Syncope",
      "description": "A transient loss of consciousness and postural tone due to temporary insufficient blood flow to the brain.",
      "features": ["Transient LOC", "Prodrome (lightheadedness, diaphoresis)"],
      "workup": [
        "ECG [WHY: Identifies arrhythmias, conduction blocks, or ischemia causing syncope - abnormal ECG predicts cardiac cause]",
        "Orthostatics [WHY: >20 mmHg SBP drop or >10 mmHg DBP drop indicates orthostatic hypotension as cause]",
        "Echo if structural disease [WHY: Structural heart disease increases risk of cardiac syncope, guides need for further monitoring]",
        "Holter/event monitor [WHY: Captures intermittent arrhythmias missed on single ECG, correlates symptoms with rhythm abnormalities]"
      ],
      "management": [
        "Reassurance, hydration, avoid triggers for vasovagal",
        "Treat arrhythmia, pacemaker/ICD if indicated for cardiac causes",
        "Fluids, compression stockings, adjust meds for orthostatic"
      ],
      "pearls": ["Avoid triggers", "Cardiology/neurology as indicated"]
    },
    {
      "id": "takotsubo",
      "name": "Takotsubo (Stress) Cardiomyopathy",
      "description": "A temporary heart condition often triggered by stress, resembling a heart attack.",
      "features": ["Chest pain", "Dyspnea", "Syncope"],
      "workup": [
        "Coronary angiography to exclude ACS",
        "Echo",
        "ECG",
        "Troponin"
      ],
      "management": [
        "Supportive (HF therapy)",
        "Avoid inotropes unless shock",
        "Usually recovers within weeks"
      ],
      "pearls": ["Avoid stressors", "Medication adherence", "Cardiology"]
    },
    {
      "id": "tof",
      "name": "Tetralogy of Fallot (TOF)",
      "description": "A cyanotic congenital heart defect characterized by four findings: right ventricular hypertrophy, ventricular septal defect, overriding aorta, and right ventricular outflow tract obstruction.",
      "features": [
        "Cyanosis: degree depends on severity of RVOT obstruction",
        "Harsh systolic ejection murmur at left sternal border",
        "Clubbing of fingers/toes",
        "Tet spells: hypercyanotic episodes (lips and extremities turn blue)",
        "Triggered by crying, feeding, or exertion",
        "Dyspnea on exertion",
        "Syncope or seizures during severe spells",
        "Failure to thrive in infancy",
        "Squatting position to relieve symptoms"
      ],
      "workup": [
        "Echocardiogram: VSD, RVOT obstruction, overriding aorta, RVH",
        "ECG: RVH, right axis deviation",
        "Chest X-ray: 'boot-shaped' heart from RVH",
        "Cardiac catheterization: most accurate for anatomy and pressures",
        "Labs: oxygen saturation monitoring"
      ],
      "management": [
        "Acute tet spells: knee-chest position, oxygen, morphine, propranolol, IV fluids",
        "Surgical repair: typically in infancy (VSD closure + RVOT relief)",
        "Palliative shunt: if surgery delayed (Blalock-Taussig shunt)",
        "Post-repair: monitor for pulmonary regurgitation, arrhythmias, RV dysfunction",
        "Endocarditis prophylaxis: if prosthetic material used",
        "Genetic counseling: consider for associated syndromes"
      ],
      "pearls": [
        "Tet spells: bring knees to chest to increase systemic vascular resistance and decrease right-to-left shunt",
        "Surgical repair typically performed at 3-6 months of age",
        "Monitor for residual RVOT obstruction, pulmonary regurgitation, arrhythmias",
        "Long-term complications: sudden cardiac death, heart failure, arrhythmias",
        "Pregnancy generally well-tolerated after repair but requires monitoring",
        "Report cyanosis, difficulty feeding, poor growth, or tet spells",
        "Lifelong congenital cardiology care",
        "Annual echocardiograms and cardiology follow-up",
        "Exercise restrictions may be needed based on residual lesions"
      ]
    },
    {
      "id": "torsades",
      "name": "Torsades de Pointes",
      "description": "Polymorphic ventricular tachycardia associated with prolonged QT interval, characterized by twisting of the QRS axis around the baseline.",
      "features": [
        "Sudden onset polymorphic VT",
        "Associated with prolonged QT interval",
        "Syncope, cardiac arrest, sudden death",
        "Drug-induced (antiarrhythmics, antibiotics, antipsychotics)",
        "Electrolyte abnormalities (hypokalemia, hypomagnesemia)",
        "Congenital long QT syndrome",
        "May be pause-dependent"
      ],
      "workup": [
        "12-lead ECG: Polymorphic VT with QT prolongation",
        "QT interval measurement (correct for heart rate)",
        "Electrolyte panel: Potassium, magnesium, calcium",
        "Medication review: QT-prolonging drugs",
        "Echocardiogram: Rule out structural disease",
        "Genetic testing: For congenital long QT",
        "Holter monitor: Document QT changes",
        "Exercise testing: Assess QT response"
      ],
      "management": [
        "Remove offending drugs and correct electrolytes",
        "Magnesium sulfate 2g IV (first-line)",
        "Temporary pacing for bradycardia-dependent TdP",
        "Isoproterenol infusion for congenital long QT",
        "Unstable: Defibrillation (unsynchronized)",
        "ICD for secondary prevention",
        "Beta-blockers for congenital long QT",
        "Avoid QT-prolonging drugs long-term"
      ],
      "pearls": [
        "Magnesium is first-line despite normal magnesium levels",
        "TdP often pause-dependent (long-short sequence)",
        "Drug-induced TdP most common cause",
        "Congenital long QT: Beta-blockers prevent TdP",
        "QT >500ms significantly increases TdP risk",
        "Electrolyte correction essential",
        "ICD prevents sudden death in high-risk patients",
        "Family screening for congenital cases"
      ]
    },
    {
      "id": "transposition_great_vessels",
      "name": "Transposition of the Great Vessels (TGA)",
      "description": "A cyanotic congenital heart defect where the aorta is connected to the right ventricle and the pulmonary artery is connected to the left ventricle, resulting in parallel circulation.",
      "features": [
        "Severe cyanosis within first hours of life",
        "Tachypnea and respiratory distress",
        "Loud S2 from pulmonary hypertension",
        "Signs of congestive heart failure",
        "Differential cyanosis (blue upper body, pink lower body)",
        "Murmur from associated defects",
        "Poor feeding and lethargy"
      ],
      "workup": [
        "Echocardiogram: diagnostic test, shows abnormal vessel connections",
        "ECG: RVH, right axis deviation",
        "Chest X-ray: 'egg on a string' sign (egg-shaped heart with narrow mediastinum)",
        "Arterial blood gas: severe hypoxemia",
        "Labs: metabolic acidosis from poor perfusion"
      ],
      "management": [
        "Prostaglandins: keep ductus arteriosus open for mixing",
        "Balloon atrial septostomy: emergency procedure to improve mixing",
        "Arterial switch operation: definitive surgical correction in first 2 weeks",
        "Medical management: inotropic support, ventilation",
        "Post-operative: monitor for coronary artery complications",
        "Long-term follow-up for arrhythmias and coronary artery disease"
      ],
      "pearls": [
        "Requires both ASD and PDA for survival (allows mixing of blood)",
        "Arterial switch operation is gold standard (performed at 1-2 weeks)",
        "Monitor for coronary artery complications post-switch",
        "Risk of arrhythmias and sudden cardiac death",
        "Associated with maternal diabetes and advanced maternal age",
        "Report cyanosis, poor feeding, lethargy, or respiratory distress",
        "Lifelong congenital cardiology care",
        "Annual echocardiograms and stress testing",
        "Pregnancy generally well-tolerated but requires specialized care"
      ]
    },
    {
      "id": "tr",
      "name": "Tricuspid Regurgitation",
      "description": "Backflow of blood from the right ventricle into the right atrium due to tricuspid valve insufficiency.",
      "features": [
        "Etiology: Most commonly dilation of right atrium and ventricle",
        "Symptoms: Right-sided heart failure signs",
        "Murmur: Holosystolic murmur at left mid-sternal border",
        "Fatigue",
        "Abdominal fullness",
        "Edema",
        "Ascites"
      ],
      "workup": [
        "Transthoracic echo (severity, RV size/function, annular dilation, pulmonary pressures)",
        "ECG (AF, RVH if pulmonary HTN)",
        "CXR (RA/RV enlargement, pleural effusion)"
      ],
      "management": [
        "Treatment: Diuretics; Surgery if severe",
        "Treat underlying cause (pulmonary HTN, left-sided heart disease, endocarditis, congenital)",
        "Diuretics for volume overload",
        "Surgical repair/replacement if severe symptomatic TR or undergoing left-sided surgery",
        "Transcatheter options emerging for high-risk surgical candidates"
      ],
      "pearls": [
        "Serial echo based on severity and RV function",
        "Monitor for worsening edema, ascites, fatigue",
        "Medication adherence (diuretics, anticoagulation if AF)",
        "Cardiology follow-up; consider advanced therapies if refractory symptoms",
        "Often functional rather than primary valve disease",
        "Associated with pulmonary hypertension and left-sided heart failure"
      ]
    },
    {
      "id": "ts",
      "name": "Tricuspid Stenosis",
      "description": "Narrowing of the tricuspid valve opening, restricting blood flow from the right atrium to the right ventricle.",
      "features": [
        "Etiology: Rheumatic disease or other valvular abnormalities",
        "Symptoms: Nonspecific, often signs of right heart failure",
        "Murmur: Diastolic murmur best at 4th intercostal space, left lower sternal border"
      ],
      "workup": [
        "Transthoracic echo (valve area, mean gradient, RA/RV size)",
        "ECG (RA enlargement)",
        "CXR (RA enlargement, pulmonary congestion)"
      ],
      "management": [
        "Treatment: ACE inhibitors and diuretics for control; surgery or balloon valvotomy if severe",
        "Diuretics for right heart failure symptoms",
        "Surgical repair/replacement if severe",
        "Balloon valvotomy in select cases"
      ],
      "pearls": [
        "Rare condition, often rheumatic in origin",
        "Monitor for right heart failure progression",
        "Surgical intervention for severe cases",
        "Associated with other valvular diseases",
        "Echo surveillance for progression"
      ]
    },
    {
      "id": "truncus_arteriosus",
      "name": "Truncus Arteriosus (TA)",
      "description": "A cyanotic congenital heart defect where a single great vessel arises from both ventricles, supplying both systemic and pulmonary circulation.",
      "features": [
        "Severe cyanosis at birth",
        "Tachypnea and respiratory distress",
        "Congestive heart failure symptoms",
        "Single loud systolic murmur",
        "Bounding pulses from increased pulmonary blood flow",
        "Failure to thrive",
        "Recurrent respiratory infections"
      ],
      "workup": [
        "Echocardiogram: shows single great vessel from both ventricles",
        "ECG: biventricular hypertrophy",
        "Chest X-ray: cardiomegaly, increased pulmonary vascularity",
        "Cardiac catheterization: for detailed anatomy and pressures",
        "Labs: hypoxemia, metabolic acidosis"
      ],
      "management": [
        "Prostaglandins: keep ductus arteriosus open",
        "Surgical correction: truncal valve repair + VSD closure + RV-PA conduit",
        "Typically performed in first few weeks of life",
        "Medical management: diuretics, inotropes for heart failure",
        "Long-term: conduit replacement as child grows",
        "Endocarditis prophylaxis: due to prosthetic conduit"
      ],
      "pearls": [
        "Associated with DiGeorge syndrome (22q11 deletion) in 30% of cases",
        "Type I: most common, pulmonary arteries arise from truncus",
        "Surgical repair has high mortality but good long-term outcomes",
        "Monitor for conduit stenosis, truncal valve regurgitation",
        "Risk of arrhythmias and sudden cardiac death",
        "Genetic counseling recommended",
        "Report cyanosis, poor feeding, respiratory distress",
        "Lifelong congenital cardiology care",
        "Multiple surgeries often required as child grows"
      ]
    },
    {
      "id": "vfib",
      "name": "Ventricular Fibrillation (VF)",
      "description": "Chaotic ventricular electrical activity without organized depolarization, resulting in no cardiac output or blood pressure.",
      "features": [
        "Sudden cardiac arrest",
        "No pulse, no blood pressure",
        "Agonal respirations",
        "May follow VT or occur de novo",
        "Associated with ischemia, electrolyte abnormalities",
        "Primary VF: No preceding heart disease",
        "Secondary VF: Underlying structural disease"
      ],
      "workup": [
        "ECG: Chaotic irregular deflections, no identifiable QRS",
        "Post-resuscitation: Echocardiogram, coronary angiography",
        "Electrolyte panel and toxicology screen",
        "Cardiac MRI: Evaluate for infiltrative disease",
        "Genetic testing: For channelopathies",
        "Family screening: For inherited arrhythmias",
        "ICD interrogation: If prior device present"
      ],
      "management": [
        "Immediate CPR and defibrillation (unsynchronized)",
        "ACLS protocol: Epinephrine, amiodarone",
        "Targeted temperature management (32-36°C)",
        "Coronary angiography if STEMI suspected",
        "ICD implantation for secondary prevention",
        "Address underlying causes (ischemia, electrolytes)",
        "Beta-blockers and antiarrhythmics for prevention",
        "Multidisciplinary evaluation for etiology"
      ],
      "pearls": [
        "VF requires immediate defibrillation (shock first)",
        "Survival depends on early CPR and defibrillation",
        "Most VF due to ischemic heart disease",
        "ICD reduces mortality by 50-70%",
        "Post-cardiac arrest care critical for outcomes",
        "Targeted temperature management improves survival",
        "Comprehensive evaluation to prevent recurrence",
        "Family screening for inherited causes"
      ]
    },
    {
      "id": "vsd",
      "name": "Ventricular Septal Defect (VSD)",
      "description": "A congenital heart defect characterized by a direct connection between both ventricles through a defect in the septum.",
      "features": [
        "Small VSD: often asymptomatic",
        "Moderate VSD: mild symptoms, normal growth",
        "Large VSD: heart failure symptoms in infancy (tachypnea, poor feeding, failure to thrive)",
        "Harsh holosystolic murmur at left lower sternal border (tricuspid region)",
        "Murmur does not increase with respiration",
        "Pulmonary hypertension (Eisenmenger syndrome): cyanosis, clubbing, dyspnea",
        "Recurrent respiratory infections",
        "Developmental delay in severe cases"
      ],
      "workup": [
        "Echocardiogram: defect location, size, shunt magnitude, chamber enlargement",
        "ECG: LVH, RVH with large shunts, conduction abnormalities",
        "Chest X-ray: cardiomegaly, increased pulmonary vascularity if large shunt",
        "Cardiac catheterization: reserved for cases where echo insufficient",
        "Genetic testing: consider for associated syndromes"
      ],
      "management": [
        "Small VSD: observation only, often closes spontaneously",
        "Moderate VSD: medical management of heart failure (diuretics, ACEi, nutritional support)",
        "Large VSD: surgical closure if persistent shunt with CHF, growth failure, pulmonary hypertension",
        "Eisenmenger syndrome: pulmonary vasodilators, anticoagulation, heart-lung transplant if refractory",
        "Endocarditis prophylaxis: only if residual defect at patch/device site",
        "Pulmonary hypertension management: oxygen, pulmonary vasodilators",
        "Growth optimization: adequate calories, nutritional support"
      ],
      "pearls": [
        "Eisenmenger syndrome: initially left-to-right shunt, then pulmonary HTN reverses to right-to-left",
        "Qp:Qs ratio >2:1 indicates significant shunt requiring intervention",
        "Serial echocardiograms to monitor defect size and pulmonary pressures",
        "Monitor for aortic regurgitation (supracristal VSD), arrhythmias, endocarditis",
        "Most VSDs close spontaneously by age 1-2 years",
        "Surgical repair typically performed between 3-6 months for large defects",
        "Report worsening dyspnea, poor growth, cyanosis, or edema",
        "Lifelong cardiology follow-up, especially if repaired",
        "Pregnancy generally well-tolerated but requires monitoring for pulmonary hypertension"
      ]
    },
    {
      "id": "vt",
      "name": "Ventricular Tachycardia (VT)",
      "description": "Rapid ventricular rhythm ≥100 bpm with ≥3 consecutive wide QRS complexes, originating from ventricular tissue.",
      "features": [
        "Palpitations, chest pain, shortness of breath, syncope",
        "Hemodynamic instability (hypotension, shock)",
        "May be monomorphic or polymorphic",
        "Sustained (>30 seconds) or non-sustained",
        "Associated with structural heart disease",
        "May degenerate to ventricular fibrillation",
        "R-on-T phenomenon increases VF risk"
      ],
      "workup": [
        "12-lead ECG: Wide complex tachycardia, regular rhythm, AV dissociation [WHY: Confirms VT diagnosis vs SVT with aberrancy, AV dissociation is pathognomonic for VT]",
        "Echocardiogram: Assess cardiac structure and function [WHY: Identifies structural heart disease predisposing to VT, guides ICD candidacy if EF ≤35%]",
        "Coronary angiography: Rule out ischemic disease [WHY: Ischemia is most common VT trigger, revascularization may reduce VT burden]",
        "Electrolyte panel: Magnesium, potassium abnormalities [WHY: Hypokalemia and hypomagnesemia predispose to VT, correction may terminate arrhythmia]",
        "Cardiac MRI: Evaluate for infiltrative disease [WHY: Identifies scar/fibrosis that serves as VT substrate, helps plan ablation strategy]",
        "Electrophysiology study: Induce and map VT [WHY: Confirms diagnosis, maps VT circuit for ablation, tests antiarrhythmic drug efficacy]",
        "Holter monitor: Document arrhythmia burden [WHY: Quantifies VT episodes, correlates symptoms with rhythm, guides treatment intensity]",
        "Exercise testing: Assess ischemia and arrhythmia induction [WHY: Exercise-induced VT suggests ischemic etiology or catecholaminergic VT]"
      ],
      "management": [
        "Unstable VT: Immediate synchronized cardioversion",
        "Stable VT: Antiarrhythmics (amiodarone, lidocaine, procainamide)",
        "Treat underlying cause (ischemia, electrolyte abnormalities)",
        "ICD implantation for secondary prevention",
        "Catheter ablation for recurrent VT",
        "Beta-blockers for prevention",
        "Address reversible causes (electrolytes, drugs, ischemia)",
        "Multidisciplinary approach with electrophysiology"
      ],
      "pearls": [
        "Treat all wide complex tachycardia as VT until proven otherwise",
        "VT in setting of AMI requires immediate cardioversion",
        "Polymorphic VT often due to ischemia or long QT",
        "Monomorphic VT usually due to scar-related reentry",
        "Amiodarone first-line for stable VT",
        "ICD reduces sudden cardiac death by 50-70%",
        "Ablation success rate 60-80% for scar-related VT",
        "Beta-blockers reduce VT recurrence by 30%"
      ],
      "clinical_triggers": {
        "symptoms_any": [
          "Palpitations",
          "Syncope",
          "Chest pain",
          "Dyspnea",
          "Sudden cardiac arrest"
        ],
        "signs_any": [
          "Wide-complex tachycardia on ECG (≥120 ms)",
          "AV dissociation, capture/fusion beats",
          "Hypotension, shock if unstable"
        ]
      },
      "contraindications": {
        "polymorphic_vt": [
          "Avoid antiarrhythmics if due to prolonged QT — treat as Torsades"
        ]
      },
      "discharge": {
        "instructions": [
          "Adherence to antiarrhythmic therapy if prescribed",
          "Avoid QT-prolonging meds if history of Torsades",
          "Emergency response plan if ICD shocks occur"
        ],
        "follow_up": ["Electrophysiology follow-up"]
      }
    },
    {
      "id": "watchman_postop",
      "name": "Watchman (Post-Operative Care by NP)",
      "description": "Post-operative care following Watchman left atrial appendage closure device implantation for stroke prevention in atrial fibrillation.",
      "features": [
        "Post-procedure monitoring for device-related complications",
        "Assessment of groin access sites",
        "Evaluation of cardiac rhythm and symptoms",
        "Monitoring for pericardial effusion or tamponade"
      ],
      "workup": [
        "ECHO: Post-op day 1; discharge after ECHO is complete, no gross abnormalities, LAA closed, and no pericardial effusion",
        "Monitoring: Groin sites, peripheral pulses",
        "TEE or ICE imaging to confirm device position",
        "Vital signs assessment",
        "Cardiac rhythm monitoring",
        "Neurological assessment"
      ],
      "management": [
        "Anticoagulation: Managed by operating physician",
        "Pain management at groin sites",
        "Mobilization as tolerated",
        "Diet advancement as appropriate",
        "Patient education on activity restrictions",
        "Follow-up appointment scheduling",
        "Discharge planning coordination"
      ],
      "pearls": [
        "Monitor for signs of infection at access sites",
        "Assess for device-related complications (pericardial effusion, device embolization, stroke)",
        "Ensure adequate pain control before discharge",
        "Patient education on medication adherence and follow-up",
        "Coordinate with electrophysiology team for ongoing care",
        "Document device position and LAA closure for comparison"
      ]
    },
    {
      "id": "wpw",
      "name": "Wolff-Parkinson-White Syndrome (WPW)",
      "description": "Congenital disorder with accessory pathway connecting atria and ventricles, bypassing the AV node and allowing rapid ventricular rates.",
      "features": [
        "Often asymptomatic, discovered incidentally on ECG",
        "Palpitations, dizziness, syncope, sudden cardiac death",
        "May present with SVT or atrial fibrillation with rapid ventricular response",
        "Risk of sudden death highest in young males",
        "Associated with Ebstein's anomaly",
        "Family history in some cases"
      ],
      "workup": [
        "12-lead ECG: Short PR interval, delta wave, widened QRS",
        "Exercise stress testing to assess pathway conduction",
        "Electrophysiology study (gold standard) to map accessory pathway",
        "Echocardiogram to rule out structural heart disease",
        "Holter monitor for arrhythmia documentation",
        "Consider genetic testing if familial pattern",
        "Risk stratification for sudden cardiac death"
      ],
      "management": [
        "Asymptomatic patients: No treatment, regular follow-up",
        "Symptomatic patients: Catheter ablation (first-line, curative)",
        "Acute SVT: Procainamide or amiodarone (avoid AV nodal blockers)",
        "High-risk patients: ICD consideration if ablation not possible",
        "Avoid digoxin, beta-blockers, calcium channel blockers",
        "Driving restrictions during evaluation period",
        "Family screening for first-degree relatives",
        "Regular cardiology follow-up for risk reassessment"
      ],
      "pearls": [
        "Accessory pathway allows rapid ventricular rates in AF",
        "AV nodal blockers contraindicated (may accelerate ventricular rate)",
        "Ablation success rate >95%, low complication rate",
        "Risk of sudden death ~0.1% per year in asymptomatic patients",
        "WPW pattern on ECG ≠ WPW syndrome (symptoms required)",
        "EPS essential for risk stratification",
        "Young athletes with WPW require evaluation before participation",
        "Pregnancy safe with WPW, but delivery planning required"
      ]
    }
  ]
}
